Page last updated: 2024-08-24

imiquimod and Carcinoma, Basal Cell

imiquimod has been researched along with Carcinoma, Basal Cell in 308 studies

Research

Studies (308)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (0.65)	18.2507
2000's	148 (48.05)	29.6817
2010's	125 (40.58)	24.3611
2020's	33 (10.71)	2.80

Authors

Authors	Studies
Avallone, G; Conforti, C; Dell'Aquila, C; Merli, M; Quaglino, P; Ribero, S; Zalaudek, I	1
Arits, AHMM; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Oostewechel, LCF; Sinx, KAE; Verkouteren, BJA; Vernemmen, AIP; Winnepenninckx, VJL	1
Bassukas, ID; Dounousi, E; Gaitanis, G; Koutlas, V; Pappas, C; Tsironi, T	1
Bailie, JE; Burke, B	1
Borsky, K; Chicco, M; Goodall, R; Harrison, C; Rodrigues, J; Wietek, N	1
Algarin, YA; Jambusaria-Pahlajani, A; Patel, VA; Ruiz, E	1
Hassan, S; Patel, V; Safadi, MG; Viglione, M; Zahner, SL	1
Aguila, KP; Anupol, EBJ; Balete, SL; Barcelona, MV; Castro, VCS; Espinoza-Thaebtharm, A; Fineza-Dela Cruz, AMB; Gulmatico-Flores, Z; Lansangan, PP; Ligeralde-Bascones, KI; Lim-Bueser, HG; Manrique, AMB; Olitoquit, KD; Ortiz, ACG; Palisoc, ED; Rescober-Valencia, MC; Santos, DGV; See, MRV; Sy, AJF; Sy, GC; Tana, MG; Tayag, JJS; Teo, HMT	1
Krieter, M; Schultz, E	1
Axon, E; Grindlay, DJ	1
Collins, A; Doerfler, L; Savas, J	1
Braun, TL; Dao, H; Patel, V; Rosen, T	1
Cao, XC; Duan, XB; Li, MY; Zhang, XP; Zhao, HJ	1
Boyle, GM; Cullen, JK; Parsons, PG; Simmons, JL	1
Elizalde-Amatria, AG; Elizalde-Benito, AG; Elizalde-Benito, FX; Quintana-Martínez, I; Urra-Palos, M	1
Aróstegui Aguilar, J; Azcona Rodríguez, M; Hervella Garcés, M; Martínez de Espronceda Ezquerro, I; Sarriugarte Aldecoa-Otalora, J; Yanguas Bayona, JI	1
Olabi, B; Tasker, F; Williams, HC	1
Kulakov, EL; Logan, IT; Perrett, CM	1
Mahatma, G; Sweeney, AR; Yen, MT	1
Cantisani, C; Cantoresi, F; Mercuri, SR; Paolino, G	1
Arits, AHMM; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Sinx, KAE; Winnepenninckx, VJL	1
Cheng, ST; Ke, CK; Su, YC; Sun, Y	1
Fujiwara, M; Fujiwara, S; Miura, H; Takada, M	1
Muir, J; Pitney, T	1
Mosterd, K; Sinx, K	1
Cater, Z; Gurnani, P; Marlow, M; Ogilvie, J; Sabri, AH; Scurr, DJ; Segal, J	1
Bassukas, ID; Gaitanis, G; Ganiatsa, A; Karamoutsios, A; Pappas, P; Vartholomatos, G	1
Gantenbein, L; Hammerl, V; Mueller, SM; Navarini, A; Parlar, B; Väth, H	1
Apalla, Z; Gkentsidi, T; Ioannidis, D; Kyrmanidou, E; Lallas, A; Lallas, K; Manoli, SM; Moutsoudis, A; Papadimitriou, I; Papageorgiou, C; Paschou, E; Rigas, HM; Sotiriou, E; Spyridis, I; Vakirlis, E	1
Bath-Hextall, FJ; Hogan, S; Leonardi-Bee, J; Thomson, J; Williams, HC	2
Badiavas, EV; Gonzalez, AM; Kirsner, RS; Moore, K; Nagrani, N; Nahm, WJ; Nichols, AJ; Shen, J; Zito, PM	1
Piqué-Duran, E	1
Catorze, G; Labareda, J; Miroux Catarino, A; Queirós, C; Silva, L; Viana, I	1
Gupta, P; Kaur, M; Mehta Grewal, A; Sharma, M; Singh, H; Singh, M; Zadeng, Z	1
Ahmed, E; El-Khalawany, M; Mosbeh, A; Rageh, MA; Sameh, A; Saudi, WM	1
de Coster, D; Essers, BA; Mosterd, K; Sinx, KAE	1
Ariza, S; Espinosa, S; Naranjo, M	1
Arits, AH; Essers, BAB; Hendriks, MR; Kelleners-Smeets, NW; Mosterd, K	1
De Felici, MB; Feliciani, C; Pagliarello, C; Rovesti, M; Satolli, F; Zucchi, A	1
Chiricozzi, A; Costanza, G; Di Cesare, A; Di Stefani, A; Fargnoli, MC; Ferlosio, A; Orlandi, A; Pellegrini, C; Peris, K; Piccioni, A	1
Bostanci, S; Botsali, A; Heper, AO; Kocyigit, P; Vural, S	1
Arits, AHMM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Roozeboom, MH; Sommer, A; Steijlen, PM; van Pelt, HPA	1
Kim, JYS; Kozlow, JH; Mittal, B; Moyer, J; Olencki, T; Rodgers, P	1
Ged, C; Hernández-Martín, A; Knöpfel, N; Latour, I; Taïeb, A; Torrelo, A	1
Shaw, FM; Weinstock, MA	1
Jansen, MHE; Kelleners-Smeets, NWJ; Mosterd, K; Sinx, KAE	1
Arits, AHMM; Jansen, MHE; Kelleners-Smeets, NWJ; Koekelkoren, FHJ; Mosterd, K; Nelemans, PJ; Roozeboom, MH	1
Collier, NJ; Exton, LS; Green, AC; Haylett, AK; Ibbotson, SH; Mallipeddi, R; McKenna, KE; Mohd Mustapa, MF; Morton, CA; Moseley, H; Rhodes, LE; Seukeran, D; Ward, KA; Wong, TH	1
Aberbigbe, O; Etzkorn, JR; Neal, DE; Smith, RJ	1
Arai, T; Kanda, Y; Kanzaki, A; Kariya, T; Kato, Y; Shirai, K; Tsuboi, R	1
Arora, H; Darwin, E; Kamath, P; Nouri, K	1
Balasis, S; Georgiou, S; Koumoundourou, D; Mallioris, AF; Plachouri, KM	1
Bassukas, ID; Gaitanis, G	2
Guevara-Gutiérrez, E; Hernández-Torres, M; Ledesma, GS; Ruiz-González, JF; Tlacuilo-Parra, A	1
Asgari, MM; Chren, MM; Friedman, GD; Neugebauer, R; Sokil, M; Su, KA; Zhu, Z	1
Bottoni, U; Calvieri, S; Cantisani, C; Cantoresi, F; Didona, D; Kyriakou, A; Mercuri, SR; Paolino, G; Piccolo, D; Scarnò, M; Tallarico, M	1
Arits, AHMM; Hamid, MA; Jansen, MHE; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Roozeboom, MH; van Delft, LCJ	1
Brown, TS; Jung, JY; Wetzel, M	1
Deinlein, T; El-Shabrawi-Caelen, L; Gschwandtner, M; Hofmann-Wellenhof, R; Kupsa, R; Woltsche, N; Zalaudek, I	1
Al-Mayahy, MH; Holmes, A; Marlow, M; McKenna, J; Rutland, CS; Sabri, AH; Scurr, DJ	1
Council, ML; Nemer, KM	1
Alaibac, M; Ferranti, M; Tadiotto Cicogna, G; Vaccari, D	1
Beer, HD; Belloni, B; Bloch, W; Cecconi, V; Dummer, R; Knuth, A; Matter, C; Schäfer, M; Schönewolf, N; Urosevic-Maiwald, M; van den Broek, M; Walter, A; Werner, S	1
Bassett, RL; Chon, S; Fox, PS; McKay, KM; Prieto, VG; Sambrano, BL	1
Dummer, R	1
Arits, AH; De Rooij, MJ; Essers, BA; Kelleners-Smeets, NW; Krekels, GA; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJ; Rijzewijk, JJ; Sommer, A; Spoorenberg, E; Steijlen, PM; van Geest, AJ; van Neer, PA; van Pelt, HP	1
Bassukas, ID; Nakuçi, M	1
Chitwood, K; Cohen, G; Etzkorn, J	1
Aberger, F; Esterbauer, H; Frischauf, AM; Gruber, W; Loipetzberger, A; Wolff, F	1
Banzhaf, CA; Jemec, GB; Mogensen, M; Ring, HC; Themstrup, L	1
Apalla, Z; Argenziano, G; Evangelou, G; Ioannides, D; Kyrgidis, A; Lallas, A; Lazaridou, E; Lefaki, I; Patsatsi, A; Sidiropoulos, T; Sotiriou, E; Stratigos, A; Trakatelli, M; Tzellos, T; Zalaudek, I	1
Lear, JT	1
Armstrong, SJ; Bath-Hextall, F; Colver, GB; Miller, PS; Ozolins, M; Perkins, W; Williams, HC	1
Schmutz, JL; Trechot, P	1
Crandall, ML; Gibbs, NF; Rivard, SSC	1
Erkan, F; Kaçar, SD; Karaca, Ş; Özuğuz, P	1
Arits, AH; Essers, BA; Kelleners-Smeets, NW; Mosterd, K; Nelemans, P; Spoorenberg, E	1
Martín-Gorgojo, A; Pastushenko, I	1
Arits, AH; Kelleners-Smeets, NW; Mosterd, K; Nelemans, PJ; Roozeboom, MH; Steijlen, PM	1
Bonilla, R; Jones, CA; Khandwala, MA; Solebo, AL	1
Sligh, JE	1
Gao, X; Geng, L; Shi, J; Wang, H; Xu, Y	1
Philipp-Dormston, WG	1
Knackstedt, TJ; Quitadamo, M	1
Chen, YJ; Chen, YY; Huang, SW; Kao, JK; Liang, SM; Shieh, JJ; Wang, ST; Wu, CY	1
Carneiro, RC; de Lima, PP; de Macedo, EM; Matayoshi, S; Silva, BG	1
Gaastra, MT; Hollestein, LM; Holterhues, C; Kuijpers, DI; Nijsten, TE; Schuttelaar, ML; van Hattem, S; Waalboer-Spuij, R	1
Arits, AH; Kelleners-Smeets, NW; Mosterd, K; Nelemans, PJ; Roozeboom, MH; van Kleef, L; van Marion, AM; Winnepenninckx, VJ	1
Cohen, JL; Friedman, A; Ruiz, ES	1
Baraldi, C; Dika, E; Fanti, PA; Patrizi, A; Venturi, M	1
De Raeve, L; Gutermuth, J; Keymolen, K; Pierret, L; Pintens, S	1
Papakostas, D; Stockfleth, E	1
Alaibac, M; Frigo, AC; Michelotto, A; Piaserico, S	1
Bassukas, ID; Gaitanis, G; Kalogeropoulos, CD	1
Chang, SH; Chen, YJ; Huang, JL; Huang, SW; Jiang, HY; Kao, JK; Mu, SW; Shieh, JJ; Wang, ST; Wu, CY	1
Mohd Amin, MC; Rehman, K; Yuen, NP; Zulfakar, MH	1
Caglia, M; Hashemi, P; Kim, C; Shulman, K	1
Federman, DG; Wiznia, LE	1
Aukrust, P; Kolberg, ES; Nordal, K; Norum, HM; Solhaug, V	1
Arits, AHMM; de Rooij, MJM; Essers, BAB; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Roozeboom, MH; Sommer, A; Steijlen, PM	1
Alfano, R; Argenziano, G; Kyrgidis, A; Lallas, A; Longo, C; Moscarella, E; Reggiani, C; Urech, M; Zalaudek, I	1
Abadi, R; Abbas, O; Hanna, E	1
Álvarez-Coronado, M; Costales-Álvarez, C; Fernández-Vega, L; González-Rodríguez, CM; Rozas-Reyes, P	1
Al Saïf, F; Carmi, E; Dillies, AS; Fraitag-Spinner, S; Gras-Champel, V	1
Armstrong, SJ; Bath-Hextall, F; Colver, GB; Miller, PSJ; Ozolins, M; Perkins, W; Williams, HC	1
Fazil, K; Karabulut, GO; Kaynak, P; Ocak, OB; Ozturker, C; Taskapılı, M	1
Brodland, DG; Murphy, ME; Zitelli, JA	1
Affleck, AG; Evans, A; Ezughah, FI; Fleming, CJ; Ibbotson, SH	1
Lear, JT; Madan, V; Murphy, JV; West, CA	1
Jacobs, AA; Markus, J; Rosen, T; Snavely, N	1
Calvieri, S; Curzio, M; Devirgiliis, V; Gobbi, S; Panasiti, V; Roberti, V; Rossi, M	1
Campione, E; Chimenti, S; Diluvio, L; Orlandi, A; Paternò, EJ; Terrinoni, A	1
Butler, DF; Lenis, A; Parekh, PK	1
Carroll, S; Czarnecki, C; Czarnecki, D	1
Cintra, ML; de Souza, EM; Metze, K; Rybka, MO	1
Baskan, EB; Saricaoglu, H; Toker, SC; Tunali, S; Turan, A	1
Carli, P; Chiarugi, A; De Giorgi, V; Maio, V; Massi, D; Nicoletti, P; Paglierani, M; Salvini, C; Santucci, M	1
Bauza, A; Del Pozo, LJ; Martin, A; Saus, C	1
Daudén Tello, E; Goiriz Valdés, R; Santiago Sánchez-Mateos, D	1
A Gaspari, A; Rosen, T; Tyring, SK	1
Coldiron, BM; Rogers, HW	1
Alexopoulos, EC; Bassukas, ID; Gaitanis, G; Nomikos, K; Vava, E	1
Fitzpatrick, JE; Gaspari, AA; Goldenberg, G; Gowda, S; Tillman, DK	1
Burkhardt-Pérez, P; Ruiz-Villaverde, R; Sánchez-Cano, D	1
Godbolt, A; Sriprakash, K	1
Brightman, L; Daniel, DR; Geronemus, RG; Mahlberg, MJ; Mintzis, MM; Sukal, SA	1
Bernhard, JD; Bordeaux, JS; Love, WE	1
Firoz, BF; Goldberg, LH	1
Collins, C; Harrad, RA; Kennedy, CT; Ross, AH	1
Breuninger, H; Häfner, HM; Moehrle, M; Schippert, W	1
Dinotta, F; Lacarrubba, F; Massimino, D; Micali, G; Nasca, MR	1
Armstrong, SJ; Bath-Hextall, FJ; Ozolins, M; Williams, HC	1
Chang, CC; Chen, YJ; Huang, SW; Liu, CM; Liu, KT; Lu, WC; Shieh, JJ; Tsai, JJ; Wang, YT; Wu, CY	1
Kemény, L; Nagy, N	1
Aguilar, M; Benítez, N; de Troya, M; González, M; Martin, L	1
Taeron, C	1
De'Ambrosis, B; Gebauer, K; Meng, TC; Quirk, C; Slade, HB	1
Bilaç, C; Bilaç, DB; Ermertcan, AT; Kocabaş, E; Temiz, P	1
Alfaro, J; Fernandez, J; Garcia-Martin, E; Gil, LM; Idoipe, M; Pablo, LE; Pueyo, V; Zubiri, ML	1
Cannon, PS; Huilgol, SC; O'Donnell, B; Selva, D	1
Edmonds, J; Marr, PJ; Martin, LK; Murrell, DF; Pas, HH; Rubin, AI; Sebaratnam, DF; Tran, K	1
Prokosch, V; Spaniol, K; Stupp, T; Thanos, S	1
Bruckner-Tuderman, L; Burger, B; Has, C; Itin, P; Kohlhase, J; Volz, A	1
Bassukas, ID; Gaitanis, G; Nomikos, K; Vlachos, C	1
Aguayo-Leiva, IR; Jaén-Olasolo, P; Ríos-Buceta, L	1
Fernández Tirado, FJ; García Martín, E	1
LeLeux, TM; Orengo, I; Rosen, T; Venkatarajan, S; Yang, D	1
Alfaro, J; Fernandez, FJ; Garcia-Martin, E; Gil-Arribas, LM; Idoipe, M; Pablo, LE; Pueyo, V	1
Bonnekoh, B; Fehsecke, D; Franke, I; Froster, UG; Gollnick, HP; Helmdach, M; Kraus, C; Quist, SR; Reis, A	1
Daudén, E	1
Balsamo, G; Calvieri, S; Cantisani, C; Frati, R; Mattozzi, C; Melis, L; Richetta, AG	1
Bassukas, ID; Gaitanis, G; Kalogeropoulos, C	1
Anolik, R; Brightman, L; Geronemus, R; Warycha, M	1
Akkilic-Materna, M; Komericki, P; Massone, C	1
Aguayo, R; Baradad, M; Casanova, JM; Sanmartín, V	1
Alaibac, M; Salmaso, R; Tonin, E; Zattra, E	1
Echeverria, B; Guillen, C; Llombart, B; Messeguer, F; Nagore, E; Requena, C; Sanmartin, O; Serra-Guillen, C	1
Gurgone, S; Lacarrubba, F; Micali, G; Potenza, MC	1
Arits, AH; Kelleners-Smeets, NW; Mosterd, K; Nelemans, PJ	1
El Tal, AK; MacFarlane, DF	1
Humphreys, TR; Rubenzik, MK; Schwartz, LR	1
Marghoob, AA; Tang, JY	1
Chang, CC; Chen, YJ; Huang, SW; Lin, CC; Liu, KT; Shieh, JJ; Tsai, JJ; Wu, CY	1
Brand, E; Krekels, GA; Martens, J; Neumann, HA; Ostertag, JU; van der Geer, S; van Roij, J; Verhaegh, ME	1
Attili, SK; Fleming, C; Ibbotson, SH	1
Guillén, C; Llombart, B; Messeguer, F; Requena, C; Serra-Guillén, C	1
Cooper, A; Hong, E	1
Arits, AH; Kelleners-Smeets, NW; Nelemans, PJ; Roozeboom, MH	1
Burnett, CT; Kouba, DJ	1
Sullivan, TJ	1
Firnhaber, JM	1
Brodell, RT; Tandon, Y	1
Bath-Hextall, F; Ozolins, M; Tinelli, M; Williams, HC	1
Maatouk, I; Moutran, R; Stephan, F; Tomb, R	1
Apalla, Z; Karteridou, A; Lallas, A; Lefaki, I; Sotiriou, E; Tzellos, T; Varytimiadis, D	1
Urbina, F	1
Andres, K; Geisse, JK; Ginkel, A; Gross, K; Owens, M; Pandya, A; Rich, P	1
Amies, M; Andres, K; Golitz, L; Greenway, H; Kossard, S; Owens, M; Robinson, J; Schroeter, A; Shumack, S	1
Caltabiano, R; De Pasquale, R; Impallomeni, R; Lacarrubba, F; Micali, G	1
Cowen, E; Gaspari, AA; Mercurio, MG	1
Andres, K; Bichel, J; Ding, L; Herrera, E; Ruzicka, T; Sterry, W; Takwale, A; Thissen, MR	1
Altmeyer, P; Oster-Schmidt, C; Stücker, M	1
Fox, CA; Goldgeier, M; Gonzalez, S; Harris, D; Zavislan, JM	1
Garland, SM	1
Siller, G; Whitehead, K; Wu, JK	1
Piérard, GE; Piérard-Franchimont, C; Quatresooz, P; Uhoda, I	1
Hermanns-Lê, T; Nikkels, AF; Paquet, P; Piérard, GE; Piérard-Franchimont, C	1
Goldberg, LH; Peterson, SR	1
Benninghoff, B; Bong, AB; Drewniok, C; Geilen, CC; Gollnick, H; Herz, J; Reifenberger, J; Schön, M; Schön, MP; Slade, HB	1
Gaspari, AA; Sauder, DN	1
Schmook, T; Stockfleth, E	1
Beyeler, M; Burg, G; Dummer, R; Morcinek, J	1
Benninghoff, B; Burg, G; Dummer, R; Maier, T; Slade, H; Urosevic, M	1
Hurwitz, DJ; Kupper, TS; Pincus, L	1
Chosidow, O; Dummer, R	1
Rigel, D; Shumack, S	1
Garcia-Bartels, C; Schmook, T; Sterry, W; Stockfleth, E; Trefzer, U; Wegner, T	1
Burg, G; Dummer, R; Hafner, J; Hoek, K; Kempf, W; Urosevic, M	1
Berman, B; De Araujo, T; Nadji, M; Sullivan, T	1
Botella-Estrada, R; Guillen, C; Nagore, E; Requena, C; Sanchez-Pedreño, P; Sanmartin, O; Serra-Guillen, C; Sevila, A	1
De'Ambrosis, B; Mirza, B	1
De Pasquale, R; Lacarrubba, F; Micali, G; Nasca, MR	1
Bianchi, L; Campione, E; Chimenti, S; Costanzo, A; Nisticò, S	1
Piérard, GE; Quatresooz, P	1
Roseeuw, D	1
Difonzo, EM; Giannotti, B; Pimpinelli, N; Vanzi, L	1
Reifenberger, J; Schön, MP	1
Anderson, ER; Hernandez, C; Nickoloff, B; Robinson, JK	1
Ingves, C; Jemec, GB	1
Berman, B; Dearaujo, T; Sullivan, TP; Vincek, V	1
Siller, G; Strutton, G; Wu, JK	1
Moreno, G; Shumack, S; Tran, H	1
Amonette, RA; Haque, R; Huber, A; Huber, JD; Kuwahara, RT; Skinner, RB	1
Caro, I; Geisse, J; Golitz, L; Lindholm, J; Owens, M; Stampone, P	1
Alomar, A; Vidal, D	1
Heenen, M; Monsieur, E; Petein, M; Vereecken, P	1
Schön, M; Schön, MP	1
Ladd, DJ; Lin, R; Powell, DJ; Way, BV	1
Benninghoff, B; Burg, G; Dummer, R; Hafner, J; Laine, E; Maier, T; Oberholzer, PA; Slade, H; Urosevic, M	1
Alomar, A; Matías-Guiu, X; Vidal, D	3
Huntley, A; Navi, D	1
Marks, R; Owens, M; Walters, SA	1
Gebauer, K; Macdonald, K; Owens, M; Quirk, C; Shumack, S; Walters, SA	1
Barnetson, RS; Halliday, GM; Satchell, A; Slade, HB; Zhuang, L	1
Fein, H; McGillis, ST	1
Berkes, B; González, S; Marra, D; Morgan, B; Niemeyer, A; Owens, M; Schanbacher, C; Torres, A	1
Dummer, R; Urosevic, M	1
Bieber, T; Haller, O; Tueting, T; Uerlich, M; Wenzel, J	1
Campione, E; Chimenti, S; Fargnoli, MC; Marulli, GC; Micantonio, T; Peris, K	1
Cribier, B; Ferrándiz, C; Garcia Diez, A; McRae, S; Reifenberger, J; Requena, L; Schulze, HJ; Tebbs, V	1
Nikkels, AF; Paquet, P; Piérard, GE; Piérard-Franchimont, C; Quatresooz, P	1
Keating, GM; Oldfield, V; Perry, CM	1
Marty, CL; Randle, HW; Walsh, JS	1
Keller, CD	1
Beyeler, M; Burg, G; Conrad, C; Dummer, R; Gilliet, M; Laine, E; Urosevic, M	1
Atkins, CL; Brown, VL; Cerio, R; Ghali, L; Harwood, CA; Proby, CM	1
Hauschild, A	1
Germolic, D; Hamann, MS; Kotwall, C; McCutcheon, B; Rebolloso, Y; Stiles, A; White, K	1
Dalrymple, J; Hanger, C; Hepburn, D	1
Langtry, JA; Rajan, N	1
Micali, M; Musumeci, ML; Nasca, MR	1
Balestrazzi, E; Blasi, MA; Giammaria, D	1
Khachemoune, A	1
Spencer, JM	1
Oh, C; Siller, G; Strutton, G; Wu, JK	1
Markus, J; Orengo, I; Pielop, JA; Rivera, A	1
Dissemond, J; Grabbe, S	1
Ceilley, RI; Del Rosso, JQ	1
Krekels, GA; Kuijpers, DI; Thissen, MR	1
Mendonça, CO; Yates, VM	1
Cartwright, N; Coyle, A; Fitzgerald, KA; Mitchell, JA; Silverman, N	1
Bogeschdorfer, F; Gronau, S; Riechelmann, H	1
Siller, G; Vun, Y	1
Stashower, ME	1
Takenouchi, T	1
Gebauer, K; Owens, M; Quirk, C; Stampone, P	1
Diwan, AH; Hearne, R; Polk, A; Prieto, VG; Treviño, J	1
Li, LJ; Wagamon, K	1
Abati, A; Aricó, E; Astry, C; Fetsch, P; Filie, A; Marincola, FM; Norwood, C; Panelli, MC; Selleri, S; Slade, HB; Smith, K; Stashower, ME; Walters, SA; Wang, E; Zhao, Y	1
Badía, X; Conejo-Mir, JS; Daudén, E; Guillén, C; Hamel, L; Llorens, MA; Sainz de Los Terreros, M; Vanaclocha, F	1
Khachemoune, A; Prager, R	1
Busse, H; Choontanom, R; Stupp, T; Thanos, S	1
Berthelot, C; Dickerson, MC; He, Q; Niroomand, F; Pandya, AG; Rady, P; Tyring, SK	1
Kaarniranta, K; Kontkanen, M; Leppälä, J; Uusitalo, H	1
Goldberg, RA; Huilgol, SC; Lee, S; Leibovitch, I; Selva, D	1
Blasco Melguizo, J; Bukhardt Pérez, MP; Naranjo Díaz, MJ; Naranjo Sintes, R; Ruiz-Villaverde, R	1
Cerroni, L; Kerl, H; Kodama, K; Wolf, IH	1
Bangert, C; Kopp, T; Stary, G; Stingl, G; Strohal, R; Tauber, M	1
Breuninger, H; Caroli, UM; Eigentler, TK; Garbe, C; Kamin, A; Möhrle, M; Radny, P; Weide, BM	1
Carroll, MT; Tillman, DK	2
Offner, F; Schiessl, C; Strohal, R; Tauber, M; Wolber, C	1
Falagas, ME; Papadavid, E; Stratigos, AJ	1
De Pasquale, R; Micali, G; Nasca, MR	1
Dawe, RS; Ezughah, FI; Fleming, CJ; Ibbotson, SH	1
Dummer, R; Urosevic, M; Wuest, M	1
Perry, CM; Wagstaff, AJ	1
Jorizzo, JL; Neville, JA; Williford, PM	1
Fargnoli, MC; Micantonio, T; Peris, K; Piccolo, D	1
Finato, N; Forcione, M; Frattasio, A; Patrone, P; Quinkenstein, E; Stinco, G	1
Goldberg, LH; Harting, M; Vujevich, J	1
Brownell, I	1
Berman, B	1
Ely, H; Rigel, DS; Torres, AM	1
Mitropoulos, P; Norman, R	1
Blyumin, M; Jacob, SE	1
Warshauer, BL; Warshauer, E	1
Beutner, KR; Fox, TL; Geisse, JK; Ginkel, A; Helman, D; Owens, ML	1
Amonette, R; Kagy, MK	1
Arrese, J; Claessens, N; Paquet, P; Piérard, G; Piérard-Franchimont, C	1
Amies, M; Bryden, J; Fox, TL; Gebauer, K; Marks, R; Owens, ML; Shumack, S	1
Hengge, U	1
Chen, TM; Orengo, I; Rosen, T	1
Cook-Bolden, F; Drehs, MM; Tanzi, EL; Weinberg, JM	1
Kerr, C	1
Varghese, M; Weisberg, NK	1
Salasche, S	1
Miller, R	1

Reviews

64 review(s) available for imiquimod and Carcinoma, Basal Cell

Article	Year
Imiquimod-side effects in the treatment of periocular skin cancers: A review of the literature. Dermatologic therapy, 2022, Volume: 35, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Skin Neoplasms	2022
A systematic review of observational management of cutaneous basal cell carcinoma. Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2022, Volume: 75, Issue:7 Topics: Carcinoma, Basal Cell; Humans; Imiquimod; Skin Neoplasms; United Kingdom	2022
Advances in Topical Treatments of Cutaneous Malignancies. American journal of clinical dermatology, 2023, Volume: 24, Issue:1 Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Quality of Life; Skin Neoplasms	2023
Nonsurgical Treatments for Nonmelanoma Skin Cancer. Dermatologic clinics, 2019, Volume: 37, Issue:4 Topics: Administration, Cutaneous; Anilides; Antineoplastic Agents; Antineoplastic Agents, Immunological; Biphenyl Compounds; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Programmed Cell Death 1 Receptor; Pyridines; Radiotherapy; Skin Neoplasms; Watchful Waiting	2019
A meta-analysis of treatment effects of imiquimod for basal cell carcinoma. Journal of cosmetic dermatology, 2020, Volume: 19, Issue:1 Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Disease-Free Survival; Drug Administration Schedule; Humans; Imiquimod; Neoplasm Grading; Skin Cream; Skin Neoplasms	2020
Topical treatments for skin cancer. Advanced drug delivery reviews, 2020, 01-01, Volume: 153 Topics: Administration, Cutaneous; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Diterpenes; Drug Delivery Systems; Fluorouracil; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis, Actinic; Melanoma; Neoplasms, Squamous Cell; Photochemotherapy; Retinoids; Skin; Skin Neoplasms; Ultraviolet Rays	2020
'Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial': a critical appraisal. The British journal of dermatology, 2020, Volume: 183, Issue:4 Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Photochemotherapy; Skin Neoplasms	2020
Mucosal side effects in patients treated with topical imiquimod-A scoping review of the literature. Dermatologic therapy, 2021, Volume: 34, Issue:1 Topics: Adjuvants, Immunologic; Administration, Topical; Aged, 80 and over; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Skin Neoplasms	2021
Interventions for basal cell carcinoma of the skin. The Cochrane database of systematic reviews, 2020, 11-17, Volume: 11 Topics: Adult; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Basal Cell; Cryotherapy; Female; Humans; Imiquimod; Immunocompetence; Laser Therapy; Male; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Radiotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome	2020
Interventions for basal cell carcinoma: abridged Cochrane systematic review and GRADE assessments. The British journal of dermatology, 2021, Volume: 185, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Humans; Imiquimod; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Skin Neoplasms; Young Adult	2021
Nonsurgical Therapies for Basal Cell Carcinoma: A Review. Actas dermo-sifiliograficas, 2017, Volume: 108, Issue:9 Topics: Administration, Cutaneous; Aminoquinolines; Anilides; Antineoplastic Agents; Biphenyl Compounds; Carcinoma, Basal Cell; Clinical Trials as Topic; Fluorouracil; Humans; Imiquimod; Interferons; Meta-Analysis as Topic; Molecular Targeted Therapy; Neoplasm Invasiveness; Photochemotherapy; Pyridines; Randomized Controlled Trials as Topic; Risk Assessment; Skin Neoplasms	2017
Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis. The British journal of dermatology, 2018, Volume: 179, Issue:6 Topics: Administration, Topical; Antineoplastic Agents; Carcinoma, Basal Cell; Cryosurgery; Dose Fractionation, Radiation; Esthetics; Humans; Imiquimod; Neoplasm Recurrence, Local; Pain; Pain Measurement; Patient Safety; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome	2018
A Review on Imiquimod Therapy and Discussion on Optimal Management of Basal Cell Carcinomas. Clinical drug investigation, 2018, Volume: 38, Issue:10 Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Disease Management; Humans; Imiquimod; Mohs Surgery; Skin Neoplasms; Treatment Outcome	2018
Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer. Dermatologic clinics, 2019, Volume: 37, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemoprevention; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Niacinamide; Photochemotherapy; Retinoids; Skin Neoplasms	2019
Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:9 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bleomycin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Interferon alpha-2; Interferon-alpha; Keratoacanthoma; Methotrexate; Recombinant Proteins; Skin Neoplasms	2013
New perspectives in the management of basal cell carcinoma. Actas dermo-sifiliograficas, 2014, Volume: 105, Issue:9 Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Disease Management; Humans; Imiquimod; Immunotherapy; Molecular Targeted Therapy; Neoplasm Proteins; Pyridines; Receptors, G-Protein-Coupled; Skin Neoplasms; Smoothened Receptor	2014
New therapeutic options for actinic keratosis and basal cell carcinoma. Seminars in cutaneous medicine and surgery, 2014, Volume: 33, Issue:4 Suppl Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Cryosurgery; Diterpenes; Humans; Imiquimod; Keratosis, Actinic; Mutation; Patched Receptors; Pyridines; Receptors, Cell Surface; Skin Neoplasms; Treatment Outcome	2014
Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis. Photodermatology, photoimmunology & photomedicine, 2015, Volume: 31, Issue:1 Topics: Administration, Topical; Aminoquinolines; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Incidence; Neoplasm Recurrence, Local; Photochemotherapy; Skin Neoplasms; Time Factors	2015
Before or after: is there a connection between the use of adjunctive nonmelanoma skin cancer treatments and subsequent invasive tumors? Journal of drugs in dermatology : JDD, 2015, Volume: 14, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Skin Neoplasms	2015
Topical treatment of basal cell carcinoma with the immune response modifier imiquimod. Future oncology (London, England), 2015, Volume: 11, Issue:22 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Humans; Imiquimod; Immunologic Factors; Neoplasm Staging; Product Surveillance, Postmarketing; Skin Neoplasms; Treatment Outcome	2015
Treatment of Basal Cell Carcinoma in the Elderly: What Nondermatologists Need to Know. The American journal of medicine, 2016, Volume: 129, Issue:7 Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Dermatologic Surgical Procedures; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Pyridines; Radiotherapy; Skin Neoplasms	2016
Imiquimod in dermatology: an overview. International journal of dermatology, 2016, Volume: 55, Issue:8 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Condylomata Acuminata; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Prognosis; Skin Diseases; Skin Neoplasms; Treatment Outcome	2016
Beyond a decade of 5% imiquimod topical therapy. Journal of drugs in dermatology : JDD, 2009, Volume: 8, Issue:5 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Condylomata Acuminata; Humans; Imiquimod; Keratosis, Actinic; Papillomavirus Infections; Skin Diseases; Skin Neoplasms; Toll-Like Receptor 7	2009
Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma. The Australasian journal of dermatology, 2009, Volume: 50, Issue:3 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Biopsy, Needle; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Hypopigmentation; Imiquimod; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Risk Assessment; Skin Neoplasms; Vitiligo	2009
Imiquimod for superficial and in situ skin malignancy. Drug and therapeutics bulletin, 2009, Volume: 47, Issue:10 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Skin Neoplasms	2009
Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Archives of dermatology, 2009, Volume: 145, Issue:12 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Metabolic Clearance Rate; Skin Neoplasms	2009
Treating skin cancer with topical cream. Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:9 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Retinoids; Skin Neoplasms	2010
[New perspective in immunotherapy: local imiquimod treatment]. Orvosi hetilap, 2010, May-09, Volume: 151, Issue:19 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antiviral Agents; Carcinoma, Basal Cell; Condylomata Acuminata; Dendritic Cells; Humans; Imiquimod; Immunity, Innate; Keratosis, Actinic; Langerhans Cells; Off-Label Use; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8; Toll-Like Receptors	2010
Do lasers or topicals really work for nonmelanoma skin cancers? Seminars in cutaneous medicine and surgery, 2011, Volume: 30, Issue:1 Topics: Administration, Cutaneous; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemexfoliation; Dermatologic Agents; Fluorouracil; Humans; Imiquimod; Laser Therapy; Nicotinic Acids; Paget Disease, Extramammary; Photochemotherapy; Skin Neoplasms	2011
Successful treatment and management of large superficial basal cell carcinomas with topical imiquimod 5% cream: a case series and review. The Journal of dermatological treatment, 2011, Volume: 22, Issue:6 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy, Needle; Carcinoma, Basal Cell; Emollients; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Sampling Studies; Skin Neoplasms; Time Factors; Treatment Outcome	2011
Emerging treatments and signaling pathway inhibitors. Seminars in cutaneous medicine and surgery, 2011, Volume: 30, Issue:4 Suppl Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Basal Cell Nevus Syndrome; Benzamides; Carcinoma, Basal Cell; Deoxyribonuclease (Pyrimidine Dimer); Fluorouracil; Hedgehog Proteins; Humans; Imiquimod; Photochemotherapy; Pyridines; Quinazolines; Retinoids; Secondary Prevention; Signal Transduction; Skin Neoplasms; Viral Proteins	2011
Role of non-surgical therapies in the management of periocular basal cell carcinoma and squamous intra-epidermal carcinoma: a case series and review of the literature. Photodermatology, photoimmunology & photomedicine, 2012, Volume: 28, Issue:2 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Eye; Female; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Skin Neoplasms	2012
Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. The British journal of dermatology, 2012, Volume: 167, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Disease-Free Survival; Humans; Imiquimod; Photochemotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome	2012
Imiquimod-induced depigmentation: report of two cases and review of the literature. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2012, Volume: 38, Issue:11 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Hypopigmentation; Imiquimod; Male; Middle Aged; Skin Neoplasms; Vitiligo	2012
Topical therapies for periorbital cutaneous malignancies: indications and treatment regimens. Current opinion in ophthalmology, 2012, Volume: 23, Issue:5 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Fluorouracil; Humans; Imiquimod; Mitomycin; Orbital Neoplasms; Skin Neoplasms	2012
Diagnosis and treatment of Basal cell and squamous cell carcinoma. American family physician, 2012, Jul-15, Volume: 86, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryotherapy; Curettage; Dermatologic Surgical Procedures; Desiccation; Fluorouracil; Humans; Imiquimod; Mohs Surgery; Risk Factors; Skin; Skin Neoplasms	2012
Local reactions to imiquimod in the treatment of basal cell carcinoma. Dermatology online journal, 2012, Sep-15, Volume: 18, Issue:9 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Keratosis, Actinic; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome	2012
Imiquimod. Current opinion in infectious diseases, 2003, Volume: 16, Issue:2 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Condylomata Acuminata; Humans; Imiquimod; Interferon Inducers; Molluscum Contagiosum; Skin Neoplasms	2003
Immunotherapy of basal cell carcinoma: evolving approaches. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2003, Volume: 29, Issue:10 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Immunity; Immunotherapy; Skin Neoplasms; Sunlight; Ultraviolet Rays	2003
Current treatment patterns in non-melanoma skin cancer across Europe. The Journal of dermatological treatment, 2003, Volume: 14 Suppl 3 Topics: Administration, Cutaneous; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryotherapy; Dermatology; Europe; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Skin Neoplasms	2003
[Cutaneous neoplasms]. Praxis, 2003, Sep-03, Volume: 92, Issue:36 Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Hemangiosarcoma; HIV Infections; Humans; Imiquimod; Immunotherapy; Keratosis; Lymph Node Excision; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Neoplasm Recurrence, Local; Photochemotherapy; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin; Skin Neoplasms; Time Factors	2003
Imiquimod: mode of action and therapeutic potential. Acta dermato-venereologica. Supplementum, 2003, Issue:214 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Imiquimod; Immune System; Papillomaviridae; Papillomavirus Infections; Skin Diseases; Skin Neoplasms	2003
Treatment of non-melanoma skin cancer: immunotherapy as a viable option. Acta dermato-venereologica. Supplementum, 2003, Issue:214 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Clinical Trials as Topic; Humans; Imiquimod; Keratosis; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays	2003
The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview. The British journal of dermatology, 2003, Volume: 149 Suppl 66 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Clinical Trials, Phase II as Topic; Cytokines; Humans; Imiquimod; Membrane Glycoproteins; Receptors, Cell Surface; Skin Neoplasms; Th1 Cells; Toll-Like Receptor 7; Toll-Like Receptors; Treatment Outcome	2003
Topical and light-based treatments for basal cell carcinoma. Seminars in cutaneous medicine and surgery, 2003, Volume: 22, Issue:3 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Immunotherapy; Interferons; Laser Therapy; Photochemotherapy; Skin Neoplasms	2003
Combined imiquimod and acitretin for non-surgical treatment of basal cell carcinoma. Scandinavian journal of plastic and reconstructive surgery and hand surgery, 2003, Volume: 37, Issue:5 Topics: Acitretin; Algorithms; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Drug Synergism; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms; Treatment Outcome	2003
Imiquimod as a dermatological therapy. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:2 Topics: Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Child; Child, Preschool; Condylomata Acuminata; Dermatologic Agents; Female; Humans; Imiquimod; Male; Molluscum Contagiosum; Photosensitivity Disorders; Randomized Controlled Trials as Topic	2004
Immune modulation and apoptosis induction: two sides of the antitumoral activity of imiquimod. Apoptosis : an international journal on programmed cell death, 2004, Volume: 9, Issue:3 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Basal Cell; Caspases; Cytochrome c Group; Enzyme Activation; Humans; Imiquimod; Melanoma; Mitochondria; Models, Biological; Neoplasms; Ointments; Proto-Oncogene Proteins c-bcl-2; Skin Neoplasms; Vascular Neoplasms	2004
Imiquimod 5 percent cream and the treatment of cutaneous malignancy. Dermatology online journal, 2004, Jul-15, Volume: 10, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Clinical Trials as Topic; Condylomata Acuminata; Drug Screening Assays, Antitumor; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunity, Cellular; Immunologic Factors; Keratoacanthoma; Keratosis; Male; Melanoma; Multicenter Studies as Topic; Mycosis Fungoides; Ointments; Paget Disease, Extramammary; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Neoplasms	2004
Topical treatment strategies for non-melanoma skin cancer and precursor lesions. Seminars in cutaneous medicine and surgery, 2004, Volume: 23, Issue:3 Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photochemotherapy; Precancerous Conditions; Skin Neoplasms; Sunlight	2004
Role of imiquimod in skin cancer treatment. American journal of clinical dermatology, 2004, Volume: 5, Issue:6 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Imiquimod; Immunologic Factors; Melanoma; Skin Neoplasms	2004
[How I treat ... basal cell carcinoma by imiquimod]. Revue medicale de Liege, 2005, Volume: 60, Issue:4 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Humans; Imiquimod; Skin Neoplasms	2005
Imiquimod: in superficial basal cell carcinoma. American journal of clinical dermatology, 2005, Volume: 6, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Multicenter Studies as Topic; Ointments; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome	2005
[Non-surgical therapy of basal cell carcinoma of the head-neck region]. Laryngo- rhino- otologie, 2006, Volume: 85, Issue:2 Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Diclofenac; Female; Humans; Imiquimod; Immunotherapy; Interferon Inducers; Interferons; Laser Therapy; Male; Ointments; Photochemotherapy; Prognosis; Radiotherapy Dosage; Skin Neoplasms; Time Factors; Urea	2006
Current modalities and new advances in the treatment of basal cell carcinoma. International journal of dermatology, 2006, Volume: 45, Issue:5 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cryosurgery; Curettage; Electrosurgery; Humans; Imiquimod; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Skin Neoplasms	2006
[New substances in the therapy of head and neck cancer]. Laryngo- rhino- otologie, 2006, Volume: 85, Issue:7 Topics: Administration, Oral; Aminoquinolines; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Basal Cell; Carcinoma, Non-Small-Cell Lung; Cetuximab; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Double-Blind Method; Erlotinib Hydrochloride; Fibroblast Growth Factor 7; Gefitinib; Head and Neck Neoplasms; Humans; Imiquimod; Infusions, Intravenous; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Ointments; Protein Kinase Inhibitors; Quinazolines; Radioimmunotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Time Factors; United States; United States Food and Drug Administration	2006
[Basal cell carcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:10 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Mohs Surgery; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2006
Pharmacological treatments for basal cell carcinoma. Drugs, 2007, Volume: 67, Issue:6 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Injections, Intralesional; Photochemotherapy; Skin Neoplasms	2007
Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:11 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Carcinoma, Basal Cell; Humans; Imiquimod; Photosensitivity Disorders; Precancerous Conditions; Skin Diseases; Skin Neoplasms	2007
Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions. Drugs, 2007, Volume: 67, Issue:15 Topics: Aminoquinolines; Animals; Antineoplastic Agents; Carcinoma, Basal Cell; Condylomata Acuminata; Humans; Imiquimod; Photosensitivity Disorders; Skin Diseases; Skin Neoplasms	2007
Scientific rationale: combining imiquimod and surgical treatments for basal cell carcinomas. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:1 Suppl 1 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cicatrix; Combined Modality Therapy; Humans; Imiquimod; Skin Neoplasms	2008
Nevoid basal cell carcinoma syndrome (Gorlin syndrome): updated review of minimally invasive treatments. Cutis, 2008, Volume: 81, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Cryosurgery; Electrochemotherapy; Fluorouracil; Humans; Imiquimod; Immunologic Factors; Interferons; Photochemotherapy; Randomized Controlled Trials as Topic; Retinoids; Skin Neoplasms	2008
Treatment of a large superficial basal cell carcinoma with 5% imiquimod: a case report and review of the literature. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2002, Volume: 28, Issue:4 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Arm; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms	2002
Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2002, Volume: 28, Issue:5 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms	2002

Trials

54 trial(s) available for imiquimod and Carcinoma, Basal Cell

Article	Year
Randomized trial of topical ascorbic acid in DMSO versus imiquimod for the treatment of basal cell carcinoma. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 148 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Ascorbic Acid; Carcinoma, Basal Cell; Dimethyl Sulfoxide; Humans; Imiquimod; Skin Neoplasms; Treatment Outcome	2022
Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial. Journal of the American Academy of Dermatology, 2020, Volume: 83, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Combined Modality Therapy; Curettage; Dermatologic Surgical Procedures; Disease-Free Survival; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Skin; Skin Cream; Skin Neoplasms	2020
Patient preferences for the attributes of a noninvasive treatment for superficial basal cell carcinoma: a discrete choice experiment. The British journal of dermatology, 2018, Volume: 178, Issue:1 Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Choice Behavior; Dermatologic Agents; Drug Therapy, Combination; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Patient Preference; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2018
Comparison of long-term cosmetic outcomes for different treatments of superficial basal cell carcinoma. Journal of the American Academy of Dermatology, 2018, Volume: 79, Issue:5 Topics: Adult; Aged; Carcinoma, Basal Cell; Dermatologic Surgical Procedures; Esthetics; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Netherlands; Photochemotherapy; Risk Assessment; Skin Neoplasms; Time Factors; Treatment Outcome	2018
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. The Lancet. Oncology, 2013, Volume: 14, Issue:7 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Prognosis; Single-Blind Method; Skin Neoplasms	2013
Immunocryosurgery for non-superficial basal cell carcinoma: a pro-spective, open-label phase III study for tumours ≤ 2 cm in diameter. Acta dermato-venereologica, 2014, Volume: 94, Issue:1 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Facial Neoplasms; Feasibility Studies; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms; Treatment Failure; Tumor Burden	2014
Optical coherence tomography imaging of non-melanoma skin cancer undergoing imiquimod therapy. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2014, Volume: 20, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Melanoma; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Tomography, Optical Coherence; Treatment Outcome	2014
Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial. The Lancet. Oncology, 2014, Volume: 15, Issue:1 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Skin Neoplasms	2014
Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma. The British journal of dermatology, 2014, Volume: 171, Issue:6 Topics: Administration, Cutaneous; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Cost Savings; Cost-Benefit Analysis; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2014
Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial. The British journal of dermatology, 2015, Volume: 172, Issue:3 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Photochemotherapy; Photosensitizing Agents; Single-Blind Method; Skin Neoplasms; Treatment Outcome	2015
Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial. BMC ophthalmology, 2015, Apr-03, Volume: 15 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Female; Follow-Up Studies; Humans; Imiquimod; Male; Neoplasm Recurrence, Local; Prospective Studies; Skin Cream; Treatment Outcome	2015
Patient Perception of Imiquimod Treatment for Actinic Keratosis and Superficial Basal Cell Carcinoma in 202 Patients. Dermatology (Basel, Switzerland), 2015, Volume: 231, Issue:1 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Quality of Life; Skin Cream; Skin Neoplasms; Surveys and Questionnaires	2015
Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial. The Journal of investigative dermatology, 2016, Volume: 136, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Proportional Hazards Models; Single-Blind Method; Skin Neoplasms; Treatment Outcome	2016
Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial. The Journal of investigative dermatology, 2017, Volume: 137, Issue:3 Topics: Administration, Topical; Adolescent; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Child; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Young Adult	2017
Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream. The Journal of dermatological treatment, 2008, Volume: 19, Issue:3 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Follow-Up Studies; Histocytological Preparation Techniques; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Skin; Skin Neoplasms; Treatment Outcome	2008
Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009, Volume: 35, Issue:1 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Double-Blind Method; Female; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Nose Neoplasms; Ointments	2009
In vivo characterization of the inflammatory infiltrate and apoptotic status in imiquimod-treated basal cell carcinoma. International journal of dermatology, 2009, Volume: 48, Issue:3 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Apoptosis; Carcinoma, Basal Cell; CD3 Complex; CD4 Antigens; Female; Humans; Imiquimod; Inflammation; Male; Middle Aged; Ointments; Skin Neoplasms; T-Lymphocyte Subsets	2009
The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma. Trials, 2010, Apr-21, Volume: 11 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cost-Benefit Analysis; Drug Costs; Female; Genotype; Health Care Costs; Humans; Imiquimod; Male; Ointments; Patient Satisfaction; Phenotype; Polymorphism, Genetic; Prospective Studies; Recurrence; Research Design; Skin Neoplasms; Time Factors; Treatment Outcome	2010
Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study. Cutis, 2010, Volume: 85, Issue:6 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms; Treatment Outcome	2010
Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma. The British journal of ophthalmology, 2011, Volume: 95, Issue:10 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Prospective Studies; Remission Induction; Treatment Outcome	2011
Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study. The British journal of dermatology, 2012, Volume: 167, Issue:1 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aminoquinolines; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Ointments; Preoperative Care; Prospective Studies; Skin Neoplasms; Treatment Outcome; Tumor Burden	2012
What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial. BMC dermatology, 2012, Oct-04, Volume: 12 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Choice Behavior; Female; Humans; Imiquimod; Male; Middle Aged; Patient Preference; Risk Factors; Skin Cream; Skin Neoplasms; Surgical Procedures, Operative; Surveys and Questionnaires	2012
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:3 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Double-Blind Method; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Skin Neoplasms	2002
Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Archives of dermatology, 2002, Volume: 138, Issue:9 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Australia; Biopsy, Needle; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; New Zealand; Probability; Prospective Studies; Reference Values; Skin Neoplasms; Treatment Outcome	2002
Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. The British journal of dermatology, 2002, Volume: 147, Issue:6 Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Administration Schedule; Drug Eruptions; Female; Humans; Imiquimod; Male; Middle Aged; Occlusive Dressings; Skin Neoplasms; Treatment Outcome	2002
Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Archives of dermatology, 2003, Volume: 139, Issue:10 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Basal Cell; Fas Ligand Protein; fas Receptor; Genes, bcl-2; Humans; Imiquimod; Intercellular Adhesion Molecule-1; Interleukin-10; Membrane Glycoproteins; Pilot Projects; Remission Induction; Skin Neoplasms	2003
Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle. The British journal of dermatology, 2003, Volume: 149 Suppl 66 Topics: Adjuvants, Immunologic; Aminoquinolines; Apoptosis; Carcinoma, Basal Cell; Case-Control Studies; fas Receptor; Humans; Imiquimod; Immunohistochemistry; Lymphocyte Activation; Single-Blind Method; Skin Neoplasms	2003
Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2003, Volume: 29, Issue:12 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Apoptosis; Carcinoma, Basal Cell; Dosage Forms; Female; Humans; Imiquimod; Lymphocytes; Male; Middle Aged; Phenotype; Skin Neoplasms	2003
Imiquimod as a dermatological therapy. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:2 Topics: Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Child; Child, Preschool; Condylomata Acuminata; Dermatologic Agents; Female; Humans; Imiquimod; Male; Molluscum Contagiosum; Photosensitivity Disorders; Randomized Controlled Trials as Topic	2004
Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2004, Volume: 30, Issue:3 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Imiquimod; Prospective Studies; Skin Neoplasms	2004
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. Journal of the American Academy of Dermatology, 2004, Volume: 50, Issue:5 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma, Basal Cell; Double-Blind Method; Female; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Ointments; Pharmaceutical Vehicles; Skin Neoplasms	2004
Efficacy of imiquimod 5% cream for basal cell carcinoma in transplant patients. Clinical and experimental dermatology, 2004, Volume: 29, Issue:3 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Heart Transplantation; Humans; Imiquimod; Immunocompromised Host; Kidney Transplantation; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2004
Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma. Clinical and experimental dermatology, 2004, Volume: 29, Issue:5 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antigens, CD; Antineoplastic Agents; Apoptosis; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Ki-67 Antigen; Male; Middle Aged; Multivariate Analysis; Neoplasm Proteins; Prospective Studies; Proto-Oncogene Proteins c-bcl-2; Skin Neoplasms; Treatment Outcome; Tumor Suppressor Protein p53	2004
Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis. The British journal of dermatology, 2004, Volume: 151, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Apoptosis; Carcinoma, Basal Cell; Cell Division; Double-Blind Method; Down-Regulation; Female; Humans; Imiquimod; Immunoenzyme Techniques; Ki-67 Antigen; Male; Middle Aged; Neoplasm Proteins; Prospective Studies; Proto-Oncogene Proteins c-bcl-2; Skin Neoplasms; Tumor Suppressor Protein p53	2004
Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas. Archives of dermatology, 2004, Volume: 140, Issue:10 Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Extremities; Female; Humans; Imiquimod; Male; Neck; Skin Neoplasms; Thorax; Treatment Outcome	2004
5% imiquimod cream for the treatment of large superficial basal cell carcinoma. Archives of dermatology, 2004, Volume: 140, Issue:10 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Australia; Carcinoma, Basal Cell; Humans; Imiquimod; New Zealand; Skin Neoplasms; Treatment Outcome	2004
Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells. Clinical and experimental dermatology, 2004, Volume: 29, Issue:6 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; CD4-Positive T-Lymphocytes; Dendritic Cells; Humans; Imiquimod; Lymphocytes, Tumor-Infiltrating; Skin Neoplasms; Treatment Outcome	2004
5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2004, Volume: 30, Issue:12 Pt 1 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Boston; California; Carcinoma, Basal Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Double-Blind Method; Female; Hospitals, University; Humans; Imiquimod; Male; Microscopy, Confocal; Middle Aged; Mohs Surgery; Predictive Value of Tests; Skin Neoplasms; Treatment Outcome	2004
Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2005, Volume: 31, Issue:3 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2005
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. The British journal of dermatology, 2005, Volume: 152, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2005
Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial. Archives of dermatology, 2005, Volume: 141, Issue:8 Topics: Acitretin; Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Double-Blind Method; Female; Humans; Imiquimod; Immunosuppression Therapy; Keratolytic Agents; Kidney Transplantation; Male; Middle Aged; Ointments; Precancerous Conditions; Risk Factors; Skin; Skin Neoplasms	2005
Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2006, Volume: 32, Issue:1 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Chemotherapy, Adjuvant; Desiccation; Double-Blind Method; Electrosurgery; Female; Humans; Imiquimod; Male; Neoplasm, Residual; Pilot Projects; Skin Neoplasms; Treatment Outcome	2006
An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma. The Australasian journal of dermatology, 2006, Volume: 47, Issue:1 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy, Needle; Carcinoma, Basal Cell; Combined Modality Therapy; Curettage; Emollients; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Risk Assessment; Single-Blind Method; Skin Neoplasms; Treatment Outcome	2006
Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks. The Australasian journal of dermatology, 2006, Volume: 47, Issue:4 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Australia; Carcinoma, Basal Cell; Drug Administration Schedule; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; New Zealand; Severity of Illness Index; Skin Neoplasms; Treatment Outcome	2006
Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection. Genome biology, 2007, Volume: 8, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; CD56 Antigen; CD8 Antigens; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Imiquimod; Interferon-alpha; Interferon-gamma; Placebos; Polymerase Chain Reaction; RNA, Messenger	2007
Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up. Archives of dermatology, 2007, Volume: 143, Issue:2 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Prospective Studies; Skin Neoplasms; Treatment Outcome	2007
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:4 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Administration Schedule; Emollients; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm, Residual; Skin Neoplasms; Treatment Outcome	2007
Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:5 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome	2007
A randomized parallel study to assess the safety and efficacy of two different dosing regimens of 5% imiquimod in the treatment of superficial basal cell carcinoma. The Journal of dermatological treatment, 2008, Volume: 19, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Administration Schedule; Female; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2008
Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:9 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Curettage; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue; Female; Headache; Humans; Imiquimod; Male; Middle Aged; Ointments; Pilot Projects; Skin Neoplasms; Treatment Outcome	2007
Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:1 Suppl 1 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Curettage; Desiccation; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome	2008
A 36-month clinical experience of the effectiveness of curettage and imiquimod 5% cream in the treatment of basal cell carcinoma. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:1 Suppl 1 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Combined Modality Therapy; Curettage; Electrosurgery; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms	2008
Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. Journal of the American Academy of Dermatology, 1999, Volume: 41, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma, Basal Cell; Double-Blind Method; Humans; Imiquimod; Interferon Inducers; Middle Aged; Skin Neoplasms; Treatment Outcome	1999
Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. Journal of the American Academy of Dermatology, 2001, Volume: 44, Issue:5 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Australia; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Imiquimod; Male; Middle Aged; New Zealand; Skin Neoplasms; Treatment Outcome	2001

Other Studies

191 other study(ies) available for imiquimod and Carcinoma, Basal Cell

Article	Year
Prognostic factors for treatment failure of imiquimod treatment in basal cell carcinoma - an observational study. Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:6 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Prognosis; Skin Neoplasms; Treatment Failure; Treatment Outcome	2022
Immunocryosurgery is a safe and feasible treatment for basal cell carcinoma and Bowen disease in renal transplant recipients. Dermatologic therapy, 2022, Volume: 35, Issue:5 Topics: Aged; Anus Neoplasms; Bowen's Disease; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Kidney Transplantation; Male; Middle Aged; Skin Neoplasms	2022
Imiquimod-induced hypertrophic lupus erythematosus-like reaction. Dermatology online journal, 2022, Aug-15, Volume: 28, Issue:4 Topics: Aged, 80 and over; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Immunologic Factors; Interferons; Lupus Erythematosus, Discoid; Skin Neoplasms; Toll-Like Receptor 7	2022
Diagnosis and management of basal cell carcinoma: interdisciplinary consensus statements of Jose R. Reyes Memorial Medical Center, a Department of Health Tertiary Hospital in Manila, Philippines. International journal of dermatology, 2023, Volume: 62, Issue:6 Topics: Carcinoma, Basal Cell; Humans; Imiquimod; Mohs Surgery; Philippines; Skin Neoplasms; Tertiary Care Centers	2023
[Current Management of Basal Cell Carcinoma]. Deutsche medizinische Wochenschrift (1946), 2023, Volume: 148, Issue:17 Topics: Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Cryotherapy; Fluorouracil; Humans; Imiquimod; Phototherapy; Radiotherapy; Skin Neoplasms	2023
Letter to the editor submitted in response to "efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a Meta-analysis of randomised controlled trial". The Journal of dermatological treatment, 2021, Volume: 32, Issue:4 Topics: Aminoquinolines; Carcinoma, Basal Cell; Humans; Imiquimod; Skin Neoplasms	2021
What are the ethical and legal considerations when your patient refuses the standard of care? Dermatology online journal, 2019, Aug-15, Volume: 25, Issue:8 Topics: Aged; Antineoplastic Agents; Carcinoma, Basal Cell; Dermatologists; Female; Humans; Imiquimod; Informed Consent; Mohs Surgery; Off-Label Use; Patient Transfer; Referral and Consultation; Refusal to Treat; Skin Neoplasms; Standard of Care; Treatment Refusal	2019
Severe balanoposthitis secondary to treatment with topical imiquimod. Archivos espanoles de urologia, 2019, Volume: 72, Issue:10 Topics: Administration, Topical; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Skin Neoplasms	2019
[Dermoscopic signs as predictors of non-response to imiquimod treatment in superficial basal cell carcinoma]. Anales del sistema sanitario de Navarra, 2019, Dec-05, Volume: 42, Issue:3 Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Carcinoma, Basal Cell; Dermoscopy; Female; Humans; Imiquimod; Male; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2019
Sequential Treatment of Superficial Basal Cell Carcinomas With Topical Methyl Aminolevulinate Photodynamic Therapy and Imiquimod 5% Cream: A Retrospective Study of Clinical and Cosmetic Outcomes. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2020, Volume: 46, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Combined Modality Therapy; Esthetics; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Cream; Skin Neoplasms; Treatment Outcome	2020
Imiquimod for Superficial Basal Cell Carcinomas. International ophthalmology clinics, 2020,Spring, Volume: 60, Issue:2 Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Skin Neoplasms	2020
Clinical evaluation and efficacy of Imiquimod 3.75% cream for the treatment of actinic keratosis, pigmented basal cell carcinomas, and actinic cheilitis. Dermatologic therapy, 2020, Volume: 33, Issue:3 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Cheilitis; Humans; Imiquimod; Keratosis, Actinic; Skin Neoplasms	2020
Successful treatment of topical imiquimod-resistant basal cell carcinoma by electronic X-ray brachytherapy. Dermatologic therapy, 2020, Volume: 33, Issue:4 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Brachytherapy; Carcinoma, Basal Cell; Electronics; Humans; Imiquimod; Skin Neoplasms; X-Rays	2020
Topical imiquimod monotherapy for a recurrent lesion of Merkel cell carcinoma. The British journal of dermatology, 2021, Volume: 184, Issue:2 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Humans; Imiquimod; Skin Neoplasms	2021
Comment on "Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial". Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:1 Topics: Carcinoma, Basal Cell; Curettage; Humans; Imiquimod; Skin Neoplasms	2021
Reply to: Comment on "Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial". Journal of the American Academy of Dermatology, 2021, Volume: 84, Issue:1 Topics: Carcinoma, Basal Cell; Curettage; Humans; Imiquimod; Skin Neoplasms	2021
Intradermal delivery of imiquimod using polymeric microneedles for basal cell carcinoma. International journal of pharmaceutics, 2020, Nov-15, Volume: 589 Topics: Administration, Cutaneous; Animals; Carcinoma, Basal Cell; Drug Delivery Systems; Imiquimod; Needles; Polymers; Skin Neoplasms; Swine	2020
Immunocryosurgery for basal cell carcinoma: impact on circulating CD4 European journal of dermatology : EJD, 2020, Oct-01, Volume: 30, Issue:5 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Humans; Imiquimod; Interferon-alpha; Interleukin-10; Lymphocyte Count; Male; Middle Aged; Skin Neoplasms; T-Lymphocytes, Regulatory; Tumor Necrosis Factor-alpha	2020
Real-life data on basal cell carcinoma treatment: Insights on clinicians' therapeutic choices from an institutional hospital registry. Dermatologic therapy, 2020, Volume: 33, Issue:6 Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Hospitals; Humans; Imiquimod; Registries; Skin Neoplasms	2020
A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers. Journal of drugs in dermatology : JDD, 2021, 03-01, Volume: 20, Issue:3 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cost-Benefit Analysis; Cryotherapy; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Tretinoin	2021
Recurrence of a Basal Cell Carcinoma in a Vitiligo-like Area After Imiquimod Treatment. Actas dermo-sifiliograficas, 2021, Volume: 112 Suppl 1 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome; Vitiligo	2021
Topical imiquimod as neoadjuvant therapy before Mohs micrographic surgery for basal cell carcinoma in the head and neck region: findings from a large retrospective study. The British journal of dermatology, 2021, Volume: 185, Issue:4 Topics: Carcinoma, Basal Cell; Humans; Imiquimod; Mohs Surgery; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2021
Long-term efficacy and safety of imiquimod 5% and fluorouracil 1% creams in medical monotherapy of complex eyelid basal cell carcinomas. European journal of ophthalmology, 2022, Volume: 32, Issue:4 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelids; Fluorouracil; Humans; Imiquimod; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2022
The combined effect of CO Journal of cosmetic dermatology, 2022, Volume: 21, Issue:5 Topics: Antineoplastic Agents; Carbon Dioxide; Carcinoma, Basal Cell; Diclofenac; Female; Humans; Imiquimod; Lasers, Gas; Male; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome	2022
Patient preferences for curettage followed by imiquimod 5% cream vs. surgical excision for the treatment of non-facial nodular basal cell carcinoma: a discrete choice experiment. Journal of the European Academy of Dermatology and Venereology : JEADV, 2022, Volume: 36, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Curettage; Humans; Imiquimod; Patient Preference; Skin Neoplasms; Treatment Outcome	2022
Multiple Basal Cell Carcinoma Arising in a Verrucous Epidermal Naevus: Clinical, Histological and Therapeutic Observations. Acta dermato-venereologica, 2018, 01-12, Volume: 98, Issue:1 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cryotherapy; Diterpenes; Female; Gels; Humans; Imiquimod; Neoplasms, Multiple Primary; Nevus, Sebaceous of Jadassohn; Skin Neoplasms; Treatment Outcome	2018
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments. PloS one, 2017, Volume: 12, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cytokines; Female; Humans; Imiquimod; Interleukin-23; Male; Middle Aged; Photochemotherapy; Real-Time Polymerase Chain Reaction; RNA, Messenger; Skin Neoplasms; Th17 Cells	2017
Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2018, Volume: 44, Issue:1 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Cream; Skin Neoplasms; Time Factors	2018
Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma. The Journal of investigative dermatology, 2018, Volume: 138, Issue:3 Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Ointments; Photochemotherapy; Skin Neoplasms	2018
Guidelines of care for the management of basal cell carcinoma. Journal of the American Academy of Dermatology, 2018, Volume: 78, Issue:3 Topics: Administration, Cutaneous; Aminoquinolines; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Dermatologic Surgical Procedures; Early Detection of Cancer; Humans; Imiquimod; Neoplasm Grading; Neoplasm Staging; Neoplasms, Second Primary; Photochemotherapy; Photosensitizing Agents; Pyridines; Radiotherapy; Skin Neoplasms; United States	2018
Reversed actinic damage in two children with xeroderma pigmentosum treated with topical imiquimod. Journal of the European Academy of Dermatology and Venereology : JEADV, 2018, Volume: 32, Issue:7 Topics: Administration, Cutaneous; Antineoplastic Agents; Carcinoma, Basal Cell; Child, Preschool; Eyelid Neoplasms; Humans; Imiquimod; Male; Nose Neoplasms; Skin Neoplasms; Xeroderma Pigmentosum	2018
Comparing Topical Treatments for Basal Cell Carcinoma. The Journal of investigative dermatology, 2018, Volume: 138, Issue:3 Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2018
Commentary on "Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma". Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2019, Volume: 45, Issue:1 Topics: Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Imiquimod; Skin Neoplasms	2019
Cells to Surgery Quiz: July 2018. The Journal of investigative dermatology, 2018, Volume: 138, Issue:7 Topics: Administration, Cutaneous; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Basal Cell; Disease-Free Survival; Drug Eruptions; Equivalence Trials as Topic; Face; Fluorouracil; Humans; Imiquimod; Male; Photochemotherapy; Photosensitizing Agents; Skin Cream; Skin Neoplasms; Treatment Outcome	2018
Response of basal cell carcinoma to imiquimod was associated with the Gli1 : Gli3 expression ratio. The British journal of dermatology, 2018, Volume: 179, Issue:6 Topics: Administration, Cutaneous; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Nerve Tissue Proteins; Skin; Skin Cream; Skin Neoplasms; Treatment Outcome; Zinc Finger Protein GLI1; Zinc Finger Protein Gli3	2018
Successful treatment of multifocal pigmented basal cell carcinomas with the application of topical 5% imiquimod cream. Dermatologic therapy, 2018, Volume: 31, Issue:5 Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Carcinoma, Basal Cell; Head and Neck Neoplasms; Humans; Imiquimod; Male; Neoplasms, Multiple Primary; Scalp; Skin Cream; Skin Neoplasms	2018
Immunocryosurgery for non-superficial basal cell carcinomas ≤ 20 mm in maximal diameter: Five-year follow-up. Journal of geriatric oncology, 2019, Volume: 10, Issue:3 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Disease-Free Survival; Follow-Up Studies; Humans; Imiquimod; Middle Aged; Prospective Studies; Skin Neoplasms	2019
[Riesgo de recurrencia y de nuevas neoplasias cutáneas malignas en sujetos mexicanos con carcinoma basocelular]. Cirugia y cirujanos, 2018, Volume: 86, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Electrocoagulation; Female; Humans; Imiquimod; Male; Margins of Excision; Middle Aged; Mohs Surgery; Neoplasms, Second Primary; Recurrence; Retrospective Studies; Risk; Skin Neoplasms; Young Adult	2018
Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study. Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4 Topics: Administration, Cutaneous; Aged; California; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Comparative Effectiveness Research; Female; Fluorouracil; Humans; Imiquimod; Intention to Treat Analysis; Keratinocytes; Keratosis, Actinic; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Risk Factors; Skin Neoplasms	2019
Sequential treatment of daylight photodynamic therapy and imiquimod 5% cream for the treatment of superficial basal cell carcinoma on sun exposed areas. Dermatologic therapy, 2019, Volume: 32, Issue:2 Topics: Aged; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Photochemotherapy; Skin Neoplasms; Sunlight; Treatment Outcome	2019
Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study. Journal of the American Academy of Dermatology, 2019, Volume: 80, Issue:4 Topics: Aged; Aminolevulinic Acid; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Equivalence Trials as Topic; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Failure	2019
Multiple Lesions in Irradiated Skin. JAMA oncology, 2019, May-01, Volume: 5, Issue:5 Topics: Adult; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Neoplasms, Radiation-Induced; Pyridines; Skin; Skin Neoplasms	2019
[Eruptive epidermoid cysts after imiquimod treatment of recurrent basal cell carcinoma : A case report]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2019, Volume: 70, Issue:5 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Epidermal Cyst; Female; Humans; Imiquimod; Skin Neoplasms; Treatment Outcome	2019
Insight into imiquimod skin permeation and increased delivery using microneedle pre-treatment. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2019, Volume: 139 Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Carcinoma, Basal Cell; Imiquimod; Models, Animal; Needles; Permeability; Skin; Skin Absorption; Skin Cream; Skin Neoplasms; Swine	2019
Topical imiquimod-induced linear IgA bullous dermatosis. BMJ case reports, 2019, Jul-19, Volume: 12, Issue:7 Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Carcinoma, Basal Cell; Dapsone; Facial Neoplasms; Female; Humans; Imiquimod; Linear IgA Bullous Dermatosis	2019
Aldara activates TLR7-independent immune defence. Nature communications, 2013, Volume: 4 Topics: Aminoquinolines; Animals; Apoptosis; Carcinoma, Basal Cell; Cell Proliferation; Cells, Cultured; Cytokines; Epidermis; Gene Expression Regulation; Humans; Imiquimod; Immunity; Inflammasomes; Interferon Type I; Keratinocytes; Keratosis, Actinic; Mice; Models, Immunological; Neutrophil Infiltration; RNA, Messenger; Skin Neoplasms; Toll-Like Receptor 7; Up-Regulation	2013
Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness-based definition of sBCC. The British journal of dermatology, 2013, Volume: 169, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Failure; Treatment Outcome	2013
Treating basal-cell carcinoma in a real life setting. The Lancet. Oncology, 2013, Volume: 14, Issue:7 Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod; Male; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2013
Office-based treatment of basal cell carcinoma with immunocryosurgery: feasibility and efficacy. Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2013, Volume: 22, Issue:2 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Ambulatory Care; Aminoquinolines; Carcinoma, Basal Cell; Cohort Studies; Cryosurgery; Feasibility Studies; Female; Follow-Up Studies; Greece; Humans; Imiquimod; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Office Visits; Risk Assessment; Skin Neoplasms; Treatment Outcome	2013
Imiquimod directly inhibits Hedgehog signalling by stimulating adenosine receptor/protein kinase A-mediated GLI phosphorylation. Oncogene, 2013, Dec-12, Volume: 32, Issue:50 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Hedgehog Proteins; Humans; Imiquimod; Kruppel-Like Transcription Factors; Medulloblastoma; Myeloid Differentiation Factor 88; Nerve Tissue Proteins; Receptors, Purinergic P1; Signal Transduction; Toll-Like Receptor 7; Toll-Like Receptor 8; Transcription Factors; Zinc Finger Protein GLI1; Zinc Finger Protein Gli3	2013
Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma. The British journal of dermatology, 2014, Volume: 170, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Dermoscopy; Humans; Imiquimod; Male; Middle Aged; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome	2014
Evidence-based treatment for low-risk basal cell carcinoma. The Lancet. Oncology, 2014, Volume: 15, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Skin Neoplasms	2014
[Psychiatric disorders associated with use of imiquimod]. Annales de dermatologie et de venereologie, 2014, Volume: 141, Issue:2 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Dementia; Depression; Female; Humans; Imiquimod; Immunologic Factors; Male; Mental Disorders; Middle Aged; Psychomotor Agitation; Skin Neoplasms; Sleep Initiation and Maintenance Disorders	2014
Giant Basal cell carcinoma. Journal of special operations medicine : a peer reviewed journal for SOF medical professionals, 2014,Spring, Volume: 14, Issue:1 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Early Detection of Cancer; Humans; Imiquimod; Laser Therapy; Male; Military Personnel; Mohs Surgery; Skin Neoplasms; Sunburn; Sunlight; Sunscreening Agents	2014
Treatment of various types of basal cell carcinoma with topical 5% imiquimod in the elderly who refused surgical intervention: a case series. The Journal of dermatological treatment, 2015, Volume: 26, Issue:2 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cryotherapy; Cytokines; Female; Humans; Imiquimod; Male; Skin Neoplasms	2015
Imiquimod 5% cream as an adjuvant pre-operative treatment for basal cell carcinoma of the periocular area. Orbit (Amsterdam, Netherlands), 2014, Volume: 33, Issue:6 Topics: Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Female; Humans; Imiquimod; Male; Middle Aged; Pilot Projects; Prospective Studies; Skin Cream; Skin Neoplasms	2014
Field cancerization: from molecular basis to selective field-directed management of actinic keratosis. Current problems in dermatology, 2015, Volume: 46 Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms	2015
Imiquimod induces sustained remission of actinic damage: a case report spanning one decade of observation. Cutis, 2015, Volume: 95, Issue:2 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Skin Neoplasms	2015
Imiquimod-induced AMPK activation causes translation attenuation and apoptosis but not autophagy. Journal of dermatological science, 2015, Volume: 78, Issue:2 Topics: Adenosine Triphosphate; Aminoquinolines; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Down-Regulation; Enzyme Activation; Gene Silencing; Humans; Imiquimod; Melanoma; Myeloid Cell Leukemia Sequence 1 Protein; Myeloid Differentiation Factor 88; Phosphorylation; Protein Biosynthesis; Protein Serine-Threonine Kinases; Signal Transduction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8	2015
Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU). Journal of the American Academy of Dermatology, 2015, Volume: 73, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Neoplasms; Treatment Failure; Tumor Burden	2015
Non-melanoma skin cancer: to Mohs or not to Mohs? Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2015, Volume: 150, Issue:5 Topics: Adult; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Follow-Up Studies; Humans; Imiquimod; Male; Microsurgery; Skin Neoplasms	2015
Xeroderma pigmentosum and leukaemia in two sisters. Journal of the European Academy of Dermatology and Venereology : JEADV, 2016, Volume: 30, Issue:10 Topics: Aminoquinolines; Carcinoma, Basal Cell; Consanguinity; Fatal Outcome; Female; Humans; Imiquimod; Leukemia; Morocco; Siblings; Xeroderma Pigmentosum	2016
TLR7 Gln11Leu single nucleotide polymorphism and response to treatment with imiquimod in patients with basal cell carcinoma: a pilot study. Pharmacogenomics, 2015, Volume: 16, Issue:17 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Resistance, Neoplasm; Female; Glutamine; Humans; Imiquimod; Leucine; Male; Pilot Projects; Polymorphism, Single Nucleotide; Skin Neoplasms; Toll-Like Receptor 7; Treatment Outcome	2015
Cryosurgery during Imiquimod (Immunocryosurgery) for Periocular Basal Cell Carcinomas: An Efficacious Minimally Invasive Treatment Alternative. Dermatology (Basel, Switzerland), 2016, Volume: 232, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Child; Combined Modality Therapy; Cryosurgery; Facial Neoplasms; Feasibility Studies; Female; Humans; Imiquimod; Male; Middle Aged; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Young Adult	2016
Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line. Journal of dermatological science, 2016, Volume: 81, Issue:3 Topics: Active Transport, Cell Nucleus; Aminoquinolines; Antineoplastic Agents; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Autophagy; Carcinoma, Basal Cell; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Imiquimod; Mutation; Phosphorylation; Reactive Oxygen Species; RNA Interference; Signal Transduction; Skin Neoplasms; Time Factors; Transfection; Tumor Suppressor Protein p53	2016
Immunomodulatory Effectiveness of Fish Oil and omega-3 Fatty Acids in Human Non-melanoma Skin Carcinoma Cells. Journal of oleo science, 2016, Volume: 65, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Drug Combinations; Fatty Acids, Omega-3; Fish Oils; Humans; Imiquimod; Immunosuppressive Agents; Interleukin-10; Interleukin-6; Skin Neoplasms; Tumor Necrosis Factor-alpha	2016
Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate. Journal of drugs in dermatology : JDD, 2016, Volume: 15, Issue:3 Topics: Acitretin; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Drug Resistance; Epidermodysplasia Verruciformis; Female; Gels; Humans; Imiquimod; Keratolytic Agents; Rare Diseases; Skin Neoplasms; Treatment Outcome; Tretinoin	2016
Rhabdomyolysis and capillary leak syndrome in a patient treated with topical imiquimod. International journal of dermatology, 2016, Volume: 55, Issue:9 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Capillary Leak Syndrome; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Rhabdomyolysis; Skin Neoplasms	2016
Dermoscopic Ulceration is a Predictor of Basal Cell Carcinoma Response to Imiquimod: A Retrospective Study. Acta dermato-venereologica, 2017, 01-04, Volume: 97, Issue:1 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Dermoscopy; Female; Humans; Imiquimod; Male; Retrospective Studies; Skin Neoplasms	2017
Topical imiquimod 5% as an alternative therapy in periocular basal cell carcinoma in two patients with surgical contraindication. Archivos de la Sociedad Espanola de Oftalmologia, 2017, Volume: 92, Issue:2 Topics: Acquired Immunodeficiency Syndrome; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Contraindications, Procedure; Eyelid Neoplasms; HIV-Associated Lipodystrophy Syndrome; Humans; Imiquimod; Male; Middle Aged; Plastic Surgery Procedures; Remission Induction; Skin Ulcer; Surgical Flaps	2017
[Eruptive epidermoid cysts during topical imiquimod treatment]. Annales de dermatologie et de venereologie, 2017, Volume: 144, Issue:3 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Diagnosis, Differential; Eyebrows; Humans; Imiquimod; Keratosis; Male; Pruritus; Skin Neoplasms	2017
Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area. Indian journal of ophthalmology, 2017, Volume: 65, Issue:1 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Eyelid Neoplasms; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Staging; Ointments; Time Factors; Treatment Outcome	2017
Definitive surgical treatment of 24 skin cancers not cured by prior imiquimod therapy: a case series. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2008, Volume: 34, Issue:9 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Male; Melanoma; Middle Aged; Mohs Surgery; Skin Neoplasms; Treatment Outcome	2008
Sequential treatment of giant basal cell carcinomas. Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2009, Volume: 62, Issue:10 Topics: Administration, Topical; Aged; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2009
Vasodilatory adverse events associated with topical imiquimod 5 percent cream. Dermatology online journal, 2008, Apr-15, Volume: 14, Issue:4 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Angioedema; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Skin; Skin Neoplasms; Urticaria	2008
Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream. Dermatology online journal, 2008, Feb-28, Volume: 14, Issue:2 Topics: Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Ointments; Photochemotherapy; Photosensitizing Agents; Remission Induction; Skin Neoplasms	2008
Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face. The Journal of dermatological treatment, 2009, Volume: 20, Issue:2 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy, Needle; Carcinoma, Basal Cell; Dermoscopy; Dose-Response Relationship, Drug; Drug Administration Schedule; Face; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Risk Assessment; Sampling Studies; Skin Neoplasms; Treatment Outcome	2009
Imiquimod treatment associated with a reduction in new skin cancer formation. Clinical and experimental dermatology, 2009, Volume: 34, Issue:1 Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Skin Neoplasms	2009
Density of dendritic cells around basal cell carcinomas is related to tumor size, anatomical site and stromal characteristics, and might be responsible for the response to topical therapy. International journal of dermatology, 2008, Volume: 47, Issue:12 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cell Count; Facial Neoplasms; Female; Humans; Imiquimod; Langerhans Cells; Male; Middle Aged; Skin Neoplasms	2008
Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNalpha-2b and topical imiquimod 5% cream. International journal of dermatology, 2009, Volume: 48, Issue:2 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Therapy, Combination; Female; Humans; Imiquimod; Interferon alpha-2; Interferon-alpha; Middle Aged; Nose Neoplasms; Recombinant Proteins; Skin Neoplasms	2009
Pemphigus-like lesions induced by imiquimod. Clinical and experimental dermatology, 2009, Volume: 34, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Eruptions; Female; Humans; Imiquimod; Middle Aged; Pemphigus; Skin Neoplasms	2009
Multiple basal cell carcinomas after radiation treatment: successful treatment with topical imiquimod. Clinical and experimental dermatology, 2010, Volume: 35, Issue:2 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Neoplasms, Radiation-Induced; Skin Neoplasms; Treatment Outcome	2010
A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. Journal of the American Academy of Dermatology, 2009, Volume: 61, Issue:1 Topics: Ambulatory Surgical Procedures; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cheek; Cost-Benefit Analysis; Curettage; Frozen Sections; Humans; Imiquimod; Mohs Surgery; Plastic Surgery Procedures; Skin Neoplasms	2009
Immunocryosurgery for basal cell carcinoma: results of a pilot, prospective, open-label study of cryosurgery during continued imiquimod application. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:12 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Feasibility Studies; Female; Humans; Imiquimod; Male; Pilot Projects; Prospective Studies; Skin Neoplasms	2009
Imiquimod-induced vitiligo after treatment of nodular basal cell carcinoma. Journal of cutaneous pathology, 2009, Volume: 36, Issue:8 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Melanocytes; Skin; Skin Neoplasms; Time Factors; Vitiligo	2009
Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:7 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms	2009
What lies beneath? A lesson for the clinician. Intraoperative frozen section appearance of persistent basal cell carcinoma after apparent cure with imiquimod 5% cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009, Volume: 35, Issue:11 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Frozen Sections; Humans; Imiquimod; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Ointments	2009
When imiquimod fails. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:5 Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Imiquimod; Leg; Male; Middle Aged; Mohs Surgery; Skin Neoplasms; Skin Transplantation; Time Factors; Treatment Failure	2010
The use of imiquimod in the treatment of periocular tumours. Orbit (Amsterdam, Netherlands), 2010, Volume: 29, Issue:2 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Eyelid Neoplasms; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2010
Letter: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Mohs Surgery; Neoadjuvant Therapy; Nose Neoplasms; Skin Neoplasms	2010
Imiquimod simultaneously induces autophagy and apoptosis in human basal cell carcinoma cells. The British journal of dermatology, 2010, Volume: 163, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Basal Cell; Caspase Inhibitors; Caspases; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Imiquimod; Skin Neoplasms; Tumor Cells, Cultured	2010
A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities. Journal of the European Academy of Dermatology and Venereology : JEADV, 2010, Volume: 24, Issue:12 Topics: Aminolevulinic Acid; Aminoquinolines; Bowen's Disease; Carcinoma, Basal Cell; Cost-Benefit Analysis; Humans; Imiquimod; Photochemotherapy; Skin Neoplasms	2010
[Imiquimod cream. A cream to use with precaution]. Revue de l'infirmiere, 2010, Issue:161 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Condylomata Acuminata; Drug Eruptions; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Skin Neoplasms; Treatment Outcome	2010
Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream. Cutaneous and ocular toxicology, 2010, Volume: 29, Issue:4 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms; Treatment Outcome	2010
Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:4 Topics: Acrylic Resins; Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cryotherapy; Eyelid Neoplasms; Eyelids; Female; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Skin Neoplasms; Treatment Outcome	2010
The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions. The British journal of ophthalmology, 2011, Volume: 95, Issue:12 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Conjunctivitis; Erythema; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2011
Reversible relapse of pemphigus foliaceus triggered by topical imiquimod suggests that Toll-like receptor 7 inhibitors may be useful treatments for pemphigus. Clinical and experimental dermatology, 2011, Volume: 36, Issue:1 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Middle Aged; Pemphigus; Skin Neoplasms; Toll-Like Receptor 7; Treatment Outcome	2011
Long-term outcome after treatment with 5% topical imiquimod cream in patients with basal cell carcinoma of the eyelids. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2011, Volume: 249, Issue:1 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Prospective Studies; Skin Neoplasms; Treatment Outcome	2011
Mild clinical phenotype of Kindler syndrome associated with late diagnosis and skin cancer. Dermatology (Basel, Switzerland), 2010, Volume: 221, Issue:4 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Basement Membrane; Blister; Carcinoma, Basal Cell; Cryosurgery; Delayed Diagnosis; Epidermolysis Bullosa; Female; Fluorouracil; Homozygote; Humans; Imiquimod; Male; Membrane Proteins; Middle Aged; Mutation; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Periodontal Diseases; Photosensitivity Disorders; Skin Neoplasms	2010
Immunocryosurgery for patients with therapeutically challenging basal cell carcinomas: report of two representative cases. The Journal of dermatological treatment, 2012, Volume: 23, Issue:1 Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Carcinoma, Basal Cell; Cryosurgery; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms	2012
[Surgical vs nonsurgical treatment of basal cell carcinoma]. Actas dermo-sifiliograficas, 2010, Volume: 101, Issue:8 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryosurgery; Fluorouracil; Follow-Up Studies; Hedgehog Proteins; Humans; Imiquimod; Interferons; Laser Therapy; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Phytotherapy; Plant Preparations; Risk Factors; Semecarpus; Skin Neoplasms; Treatment Outcome	2010
[Periocular basal cell carcinoma treatment tendencies]. Archivos de la Sociedad Espanola de Oftalmologia, 2010, Volume: 85, Issue:8 Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Conjunctival Neoplasms; Eyelid Neoplasms; Humans; Imiquimod; Immunologic Factors; Mohs Surgery; Neoplasms, Radiation-Induced; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Sunlight	2010
Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil. Dermatology online journal, 2010, Dec-15, Volume: 16, Issue:12 Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antimetabolites; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Immunologic Factors; Leg; Male; Porokeratosis; Precancerous Conditions; Remission Induction; Skin Neoplasms	2010
Complete basal cell carcinoma remission with imiquimod in a patient with nevoid basal cell carcinoma syndrome and associated basal cell carcinoma of the scalp and invasive ductal breast cancer. Journal of the American Academy of Dermatology, 2011, Volume: 64, Issue:3 Topics: Aminoquinolines; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Carcinoma, Ductal, Breast; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Imiquimod; Middle Aged; Patched Receptors; Receptors, Cell Surface; Scalp; Skin Neoplasms	2011
Effectiveness and satisfaction with imiquimod for the treatment of superficial basal cell carcinoma in daily dermatological practice. Journal of the European Academy of Dermatology and Venereology : JEADV, 2011, Volume: 25, Issue:11 Topics: Aged; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Patient Satisfaction; Prospective Studies; Skin Neoplasms	2011
Ulcerated nodular nasal basal cell carcinoma successfully treated with imiquimod 5% cream. Journal of drugs in dermatology : JDD, 2011, Volume: 10, Issue:3 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Nose Neoplasms	2011
Imiquimod can be combined with cryosurgery (immunocryosurgery) for locally advanced periocular basal cell carcinomas. The British journal of ophthalmology, 2011, Volume: 95, Issue:6 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Eyelid Neoplasms; Facial Neoplasms; Female; Humans; Imiquimod; Male; Nose Neoplasms	2011
Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer. Acta dermato-venereologica, 2011, Volume: 91, Issue:4 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Humans; Imiquimod; Immunologic Factors; Keratosis, Actinic; Lymphatic System; Male; Ointments; Skin Neoplasms; Treatment Outcome	2011
[Oral acitretin and topical imiquimod as neoadjuvant treatment for giant basal cell carcinoma]. Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:2 Topics: Acitretin; Administration, Cutaneous; Administration, Oral; Aged; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Combined Modality Therapy; Facial Neoplasms; Female; Humans; Imiquimod; Neoadjuvant Therapy; Psoriasis; Remission Induction; Skin Neoplasms; Skin Ulcer; Thoracic Neoplasms	2012
Achromic superficial spreading melanoma accidentally treated with imiquimod. Acta dermato-venereologica, 2012, Volume: 92, Issue:1 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Diagnostic Errors; Female; Humans; Imiquimod; Medication Errors; Melanoma, Amelanotic; Skin Neoplasms	2012
A pilot study of clinical efficacy of imiquimod and cryotherapy for the treatment of basal cell carcinoma with incomplete response to imiquimod. Journal of the European Academy of Dermatology and Venereology : JEADV, 2012, Volume: 26, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryotherapy; Female; Humans; Imiquimod; Male; Middle Aged; Pilot Projects; Skin Neoplasms	2012
Aesthetic evaluation after non-invasive treatment for superficial basal cell carcinoma. Journal of the European Academy of Dermatology and Venereology : JEADV, 2013, Volume: 27, Issue:5 Topics: Adult; Aged; Aminoquinolines; Carcinoma, Basal Cell; Esthetics; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Reproducibility of Results; Skin Neoplasms	2013
Cryoimmunotherapy: superficial basal cell cancer and squamous cell carcinoma in situ treated with liquid nitrogen followed by imiquimod. Archives of dermatology, 2011, Volume: 147, Issue:11 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cryotherapy; Female; Follow-Up Studies; Humans; Imiquimod; Immunotherapy; Male; Nitrogen; Retrospective Studies; Skin Neoplasms	2011
Large facial basal cell carcinoma treated with multimodal combination therapy. Cutis, 2011, Volume: 88, Issue:4 Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Combined Modality Therapy; Facial Neoplasms; Follow-Up Studies; Humans; Imiquimod; Male; Mohs Surgery; Skin Neoplasms; Treatment Outcome	2011
Mcl-1 determines the imiquimod-induced apoptosis but not imiquimod-induced autophagy in skin cancer cells. Journal of dermatological science, 2012, Volume: 65, Issue:3 Topics: Aminoquinolines; Apoptosis; Autophagy; bcl-X Protein; Biomarkers, Tumor; Carcinoma, Basal Cell; Cell Line, Tumor; Down-Regulation; Humans; Imiquimod; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Skin Neoplasms; Up-Regulation	2012
Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream. International journal of dermatology, 2012, Volume: 51, Issue:4 Topics: Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2012
Incipient retinal vein occlusion following immunotherapy of periorbital basal cell carcinoma. The Australasian journal of dermatology, 2012, Volume: 53, Issue:2 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Middle Aged; Retinal Vein Occlusion; Skin Neoplasms	2012
Treatment of nodular basal cell carcinoma with cryotherapy and reduced protocol of imiquimod. Cutis, 2012, Volume: 90, Issue:5 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryotherapy; Facial Neoplasms; Humans; Imiquimod; Male; Nose; Skin Neoplasms	2012
Letter: Immunocryotherapy for difficult-to-treat basal cell carcinoma of the eyelid. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2013, Volume: 39, Issue:1 Pt 1 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Eyelid Neoplasms; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms	2013
Giant basal cell carcinoma. Improvement and vitiligo-like hypopigmentation after intermittent treatment with 5% imiquimod. Acta dermatovenerologica Croatica : ADC, 2012, Volume: 20, Issue:4 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Head and Neck Neoplasms; Humans; Imiquimod; Scalp; Skin Neoplasms; Vitiligo	2012
Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report. The Journal of dermatological treatment, 2002, Volume: 13, Issue:3 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Skin Neoplasms	2002
An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream. Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:4 Suppl Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Skin Neoplasms	2002
Cream to be tested as skin cancer care. Expert review of anticancer therapy, 2002, Volume: 2, Issue:6 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Australia; Carcinoma, Basal Cell; Clinical Trials as Topic; Humans; Imiquimod; Skin Neoplasms; United Kingdom; United States	2002
Successful treatment of basal cell carcinoma on the face with imiquimod 5% cream. Acta dermato-venereologica, 2002, Volume: 82, Issue:6 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms; Treatment Outcome	2002
Noninvasive imaging, treatment, and microscopic confirmation of clearance of basal cell carcinoma. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2003, Volume: 29, Issue:3 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Microscopy, Confocal; Middle Aged; Skin Neoplasms	2003
Treatment of Bowen's disease and basal cell carcinoma of the nose with imiquimod 5% cream. The Australasian journal of dermatology, 2003, Volume: 44, Issue:2 Topics: Administration, Topical; Aminoquinolines; Biopsy, Needle; Bowen's Disease; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Middle Aged; Skin Neoplasms; Treatment Outcome	2003
Nudging epidermal field cancerogenesis by imiquimod. Dermatology (Basel, Switzerland), 2003, Volume: 206, Issue:4 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Humans; Imiquimod; Keratinocytes; Middle Aged; Neoplasms, Multiple Primary; Skin; Skin Neoplasms; Treatment Outcome	2003
Prolonged imiquimod treatment and graft-versus-host reaction: histological mimicry in the skin infiltration pattern of the monocyte-macrophage-dendrocyte lineage. Dermatology (Basel, Switzerland), 2003, Volume: 206, Issue:4 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Dendritic Cells; Graft vs Host Reaction; Humans; Imiquimod; Immunohistochemistry; Macrophages; Middle Aged; Monocytes; Skin; Skin Neoplasms; Tumor Necrosis Factor-alpha	2003
New and emerging treatments for nonmelanomas and actinic keratoses. Journal of drugs in dermatology : JDD, 2003, Volume: 2, Issue:4 Topics: Adjuvants, Immunologic; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diclofenac; Humans; Imiquimod; Keratosis; Photochemotherapy; Skin Neoplasms	2003
Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. Journal of the National Cancer Institute, 2003, Aug-06, Volume: 95, Issue:15 Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Caspase 3; Caspases; Cytochrome c Group; DNA Fragmentation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Imiquimod; Immunologic Factors; In Situ Nick-End Labeling; Keratinocytes; Proto-Oncogene Proteins c-bcl-2; Receptors, Tumor Necrosis Factor; Tumor Cells, Cultured; Up-Regulation	2003
Imiquimod: a topically applied link between innate and acquired immunity. Archives of dermatology, 2003, Volume: 139, Issue:10 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Immunity, Active; Immunity, Innate; Skin Neoplasms	2003
Imiquimod in basal cell carcinoma: how does it work? The British journal of dermatology, 2003, Volume: 149 Suppl 66 Topics: Adjuvants, Immunologic; Aminoquinolines; Apoptosis; Carcinoma, Basal Cell; Cytokines; Dendritic Cells; Gene Expression; Humans; Imiquimod; Immunotherapy, Active; Skin Neoplasms	2003
Excellent response of basal cell carcinomas and pigmentary changes in xeroderma pigmentosum to imiquimod 5% cream. The British journal of dermatology, 2003, Volume: 149, Issue:4 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Skin Neoplasms; Xeroderma Pigmentosum	2003
Treatment of facial superficial basal cell carcinomas with imiquimod 5% cream. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Middle Aged; Ointments; Sunlight; Treatment Outcome	2003
The use of imiquimod 5% cream for the treatment of basal cell carcinoma as observed in Gorlin's syndrome. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Skin Neoplasms; Treatment Outcome	2003
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Skin Neoplasms; Treatment Outcome	2003
Imiquimod-responsive basal cell carcinomas and factor XIIIa-enriched dendrocytes. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Carcinoma, Basal Cell; Dendritic Cells; Facial Neoplasms; Factor XIIIa; Humans; Imiquimod; Immunohistochemistry; Middle Aged; Skin Neoplasms	2003
The treatment of basal skin carcinomas in two sisters with xeroderma pigmentosum. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Skin Neoplasms; Treatment Outcome; Xeroderma Pigmentosum	2003
The treatment of basal cell carcinomas in a patient with xeroderma pigmentosum with a combination of imiquimod 5% cream and oral acitretin. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Acitretin; Administration, Oral; Administration, Topical; Adolescent; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Therapy, Combination; Facial Neoplasms; Humans; Imiquimod; Keratolytic Agents; Male; Treatment Outcome; Xeroderma Pigmentosum	2003
[Cutaneous epithelial tumors. Molecular biology and pathogenesis-based therapy]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:12 Topics: Adjuvants, Immunologic; Alleles; Aminoquinolines; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cerebellar Neoplasms; Disease Models, Animal; Genes, Tumor Suppressor; Hedgehog Proteins; Humans; Imiquimod; Medulloblastoma; Membrane Proteins; Mice; Mutation; Patched Receptors; Patched-1 Receptor; Receptors, Cell Surface; Signal Transduction; Skin Neoplasms; Trans-Activators; Transcription Factors; Tumor Cells, Cultured; Veratrum Alkaloids	2003
Psoriasis induced by topical imiquimod. The Australasian journal of dermatology, 2004, Volume: 45, Issue:1 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Interferon Inducers; Middle Aged; Psoriasis; Skin; Skin Neoplasms	2004
Imiquimod (Aldara) for actinic keratoses. The Medical letter on drugs and therapeutics, 2004, May-24, Volume: 46, Issue:1183 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Drug Administration Schedule; Humans; Imiquimod; Keratosis; Photosensitivity Disorders; Skin Neoplasms	2004
Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome. The Journal of dermatological treatment, 2004, Volume: 15, Issue:2 Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Face; Humans; Imiquimod; Male; Skin Neoplasms; Treatment Outcome	2004
Localized pemphigus foliaceus induced by topical imiquimod treatment. Archives of dermatology, 2004, Volume: 140, Issue:7 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diagnosis, Differential; Drug Eruptions; Face; Facial Dermatoses; Female; Humans; Imiquimod; Middle Aged; Pemphigus; Skin Neoplasms	2004
Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha? Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Aug-01, Volume: 10, Issue:15 Topics: Adjuvants, Immunologic; Aminoquinolines; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma, Basal Cell; Cell Line, Tumor; Cell Survival; Disease-Free Survival; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imiquimod; Immunoblotting; Immunohistochemistry; Interferon-alpha; Membrane Glycoproteins; Multigene Family; Oligonucleotide Array Sequence Analysis; Receptors, Cell Surface; Receptors, Opioid; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Toll-Like Receptor 7; Toll-Like Receptors; Treatment Outcome; Up-Regulation	2004
Minimizing surgery in skin cancer treatment. A new test looks for cancer in the lymph nodes during melanoma surgery, while a topical cream helps people with another form of skin cancer avoid the knife. Health news (Waltham, Mass.), 2005, Volume: 11, Issue:2 Topics: Adjuvants, Immunologic; Aminoquinolines; Antibodies, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Basal Cell; Humans; Imiquimod; Lymphatic Metastasis; Melanoma; Skin Neoplasms	2005
Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod. Journal of cutaneous pathology, 2005, Volume: 32, Issue:4 Topics: Adjuvants, Immunologic; Aminoquinolines; Breast Neoplasms; Carcinoma, Basal Cell; Chemotaxis, Leukocyte; Female; Humans; Imiquimod; Interferon Type I; Lymphocytes; Melanoma; Membrane Glycoproteins; Receptors, Cell Surface; Receptors, Chemokine; Receptors, CXCR3; Signal Transduction; Skin; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptors	2005
Eruptive epidermoid cysts resulting from treatment with imiquimod. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2005, Volume: 31, Issue:7 Pt 1 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Dermatologic Agents; Female; Humans; Imiquimod; Retinoids; Skin Diseases; Skin Neoplasms; Treatment Outcome	2005
Imiquimod to treat basal cell and squamous cell carcinomas. American family physician, 2005, Jul-01, Volume: 72, Issue:1 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Drug Approval; Humans; Imiquimod; Patient Selection; Skin Neoplasms; United States; United States Food and Drug Administration	2005
Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. Journal of the National Cancer Institute, 2005, Aug-03, Volume: 97, Issue:15 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Clinical Trials as Topic; Dendritic Cells; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imiquimod; Immunohistochemistry; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Microscopy, Confocal; Plasma Cells; Polymerase Chain Reaction; Skin Neoplasms	2005
[Topical immunomodulator against skin cancer. Does the cream replace the knife? (interview by Dr. Judith Neumaier)]. MMW Fortschritte der Medizin, 2005, Sep-15, Volume: 147, Issue:37 Topics: Aminoquinolines; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Humans; Imiquimod; Immunologic Factors; Ointments; Skin; Skin Neoplasms; Treatment Outcome	2005
A preliminary study of imiquimod treatment in variants of basal cell carcinoma. The American surgeon, 2005, Volume: 71, Issue:8 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Biopsy; Carcinoma, Basal Cell; Humans; Imiquimod; Pilot Projects; Polymerase Chain Reaction; Skin; Skin Neoplasms; Treatment Outcome	2005
Systemic side effects from topical imiquimod. The New Zealand medical journal, 2005, Oct-07, Volume: 118, Issue:1223 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Blood Sedimentation; Carcinoma, Basal Cell; Depression; Facial Neoplasms; Fatigue; Feeding and Eating Disorders; Humans; Hypotension, Orthostatic; Imiquimod; Male; Treatment Outcome; Weight Loss	2005
Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas. Clinical and experimental dermatology, 2006, Volume: 31, Issue:1 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Eruptions; Female; Humans; Imiquimod; Middle Aged; Psoriasis; Skin Neoplasms	2006
Treatment of an extensive superficial basal cell carcinoma of the face with imiquimod 5% cream. International journal of tissue reactions, 2005, Volume: 27, Issue:3 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Carcinoma, Basal Cell; Drug Administration Schedule; Face; Follow-Up Studies; Humans; Imiquimod; Male; Skin Neoplasms; Time Factors; Treatment Outcome	2005
Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma. American journal of ophthalmology, 2005, Volume: 140, Issue:6 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Female; Humans; Imiquimod; Immunotherapy; Interferon Inducers; Male; Ointments; Treatment Outcome	2005
A man with a pigmented growth on his chest. The Journal of family practice, 2006, Volume: 55, Issue:1 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Diagnosis, Differential; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Skin Neoplasms	2006
To the editor: incompletely excised basal cell carcinoma treated with 5% imiquimod cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2005, Volume: 31, Issue:11 Pt 1 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms	2005
Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases. Journal of drugs in dermatology : JDD, 2006, Volume: 5, Issue:5 Topics: Administration, Topical; Aged; Aminoquinolines; Biopsy, Needle; Carcinoma, Basal Cell; Chemotherapy, Adjuvant; Emollients; Female; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Middle Aged; Mohs Surgery; Neoplasm Staging; Risk Assessment; Skin Neoplasms; Treatment Outcome	2006
Permanent facial hypopigmentation following treatment with imiquimod cream. Clinical and experimental dermatology, 2006, Volume: 31, Issue:5 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Humans; Hypopigmentation; Imiquimod; Male; Steroids; Treatment Outcome	2006
TOLLing away in Brazil. Nature immunology, 2006, Volume: 7, Issue:7 Topics: Adaptor Proteins, Signal Transducing; Aminoquinolines; Animals; Antineoplastic Agents; Antiprotozoal Agents; Brazil; Carcinoma, Basal Cell; Condylomata Acuminata; Diaminopimelic Acid; Drosophila melanogaster; Drosophila Proteins; Gene Expression Regulation; Gram-Negative Bacteria; Humans; Imiquimod; Immunity, Innate; Infections; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Melanoma; Mice; Models, Immunological; Molecular Structure; Peptidoglycan; Protozoan Infections; Radiation Chimera; RNA Helicases; Signal Transduction; Skin Diseases; Skin Neoplasms; Substrate Specificity; Toll-Like Receptor 7; Toll-Like Receptors	2006
Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study. The Australasian journal of dermatology, 2006, Volume: 47, Issue:3 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Facial Neoplasms; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Mucous Membrane; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2006
Resolution of tinea pedis with imiquimod cream 5% in a patient with nodular basal cell carcinoma. Cutis, 2006, Volume: 78, Issue:1 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Skin Neoplasms; Tinea Pedis; Toes	2006
Atypical lymphocytic reaction with epidermotropism and lymphocytic vasculopathic reaction (lymphocytic vasculitis) after treatment with imiquimod. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:5 Suppl Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Lymphocytes; Skin Diseases; Skin Neoplasms; Vasculitis	2006
Recurrent invasive basal cell carcinoma after radiation and imiquimod: a case report. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:1 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Nasal Cavity; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Nose Neoplasms; Skin Neoplasms	2007
Cost-effectiveness of treatment of superficial basal cell carcinoma: surgical excision vs. imiquimod 5% cream. The British journal of dermatology, 2007, Volume: 156, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cost-Benefit Analysis; Humans; Imiquimod; Mohs Surgery; Skin Neoplasms	2007
Basal cell carcinoma. Dermatology nursing, 2006, Volume: 18, Issue:6 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Causality; Cryosurgery; Curettage; Diagnosis, Differential; Electrosurgery; Female; Fluorouracil; Humans; Imiquimod; Information Services; Interferon alpha-2; Interferon-alpha; Internet; Leg; Mohs Surgery; Nurse's Role; Patient Education as Topic; Recombinant Proteins; Skin Care; Skin Neoplasms	2006
Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: a 3-year follow-up study. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2007, Volume: 245, Issue:8 Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Humans; Imiquimod; Male; Middle Aged; Ointments; Treatment Outcome	2007
Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod. Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:5 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Epidermodysplasia Verruciformis; Humans; Imiquimod; Male; Membrane Proteins; Mutation; Skin Neoplasms	2007
Imiquimod in the treatment of eyelid basal cell carcinoma. Acta ophthalmologica Scandinavica, 2007, Volume: 85, Issue:5 Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Female; Humans; Imiquimod; Male; Ointments; Treatment Outcome	2007
Basal cell carcinoma: treatment with imiquimod. International journal of dermatology, 2007, Volume: 46, Issue:5 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Biopsy; Carcinoma, Basal Cell; Erythema; Female; Humans; Imiquimod; Male; Middle Aged; Skin; Skin Neoplasms; Spain; Time Factors; Treatment Outcome	2007
Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment. The American Journal of dermatopathology, 2007, Volume: 29, Issue:3 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Biomarkers, Tumor; Bowen's Disease; Carcinoma in Situ; Carcinoma, Basal Cell; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Inflammation; Keratosis; Male; Melanoma; Middle Aged; Skin Neoplasms	2007
Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. The Journal of experimental medicine, 2007, Jun-11, Volume: 204, Issue:6 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antibodies, Monoclonal; Antineoplastic Agents; Carcinoma, Basal Cell; Cell Line, Tumor; Cytotoxicity Tests, Immunologic; Dendritic Cells; Female; Flow Cytometry; Granzymes; Humans; Imiquimod; Immunohistochemistry; Leukocytes; Male; Perforin; TNF-Related Apoptosis-Inducing Ligand; Toll-Like Receptor 7; Toll-Like Receptor 8	2007
Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience. Cutis, 2007, Volume: 79, Issue:3 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Curettage; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome	2007
Multiple and clustered eruptive epidermoid cysts following treatment with topical imiquimod. Dermatology (Basel, Switzerland), 2007, Volume: 215, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Diagnosis, Differential; Epidermal Cyst; Facial Neoplasms; Female; Follow-Up Studies; Humans; Imiquimod; Middle Aged; Nose	2007
Induction of the members of Notch pathway in superficial basal cell carcinomas treated with imiquimod. Archives of dermatological research, 2007, Volume: 299, Issue:10 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Calcium-Binding Proteins; Carcinoma, Basal Cell; Gene Expression Profiling; Humans; Imiquimod; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Intracellular Signaling Peptides and Proteins; Jagged-1 Protein; Membrane Proteins; Polymerase Chain Reaction; Receptor, Notch1; Serrate-Jagged Proteins; Signal Transduction; Skin Neoplasms; Up-Regulation	2007
Letter: Changes in dermoscopic features in superficial basal cell carcinomas treated with imiquimod. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:11 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Dermoscopy; Drug Monitoring; Erythema; Female; Humans; Imiquimod; Immunologic Factors; Male; Middle Aged; Remission Induction; Skin Neoplasms; Skin Ulcer	2007
The appearance of inflammatory papules in the skin surrounding areas treated with imiquimod cream for basal cell carcinoma. The British journal of dermatology, 2008, Volume: 158, Issue:2 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Back; Carcinoma, Basal Cell; Humans; Imiquimod; Male; Skin Diseases, Papulosquamous; Skin Neoplasms	2008
Residual basal cell carcinoma after treatment with imiquimod: a caution on assuming complete cure. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2007, Volume: 33, Issue:12 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Neoplasm, Residual; Scalp; Skin Neoplasms; Treatment Failure	2007
Nodular basal cell carcinoma: when in doubt, cut it out. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:12 Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Mohs Surgery; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Failure	2007
Vitiligo-like hypopigmentation with poliosis following treatment of superficial basal cell carcinoma with imiquimod. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2008, Volume: 34, Issue:6 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Hypopigmentation; Imiquimod; Male; Skin Neoplasms; Thorax	2008
Clearance of basal cell and superficial squamous cell carcinomas after imiquimod therapy. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Male; Middle Aged; Retrospective Studies; Skin Neoplasms	2008
Nonsurgical therapy holds promise for basal cell carcinoma. Oncology (Williston Park, N.Y.), 1999, Volume: 13, Issue:7 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Basal Cell; Cytokines; Drug Administration Schedule; Humans; Imiquimod; Interferons; Ointments; Skin Neoplasms; Treatment Outcome	1999
The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2000, Volume: 26, Issue:6 Topics: Adjuvants, Immunologic; Aminoquinolines; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Ointments; Skin Neoplasms	2000
Dermal dendritic cells in anogenital warty lesions unresponsive to an immune-response modifier. Journal of cutaneous pathology, 2001, Volume: 28, Issue:3 Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antigen-Presenting Cells; Bowen's Disease; Carcinoma, Basal Cell; Condylomata Acuminata; Dendritic Cells; Dermis; Humans; Imiquimod; Male; Skin Neoplasms; Treatment Failure	2001
New cream to treat skin cancer? [news]. Mayo Clinic health letter (English ed.), 2001, Volume: 19, Issue:3 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Ointments; Skin Neoplasms	2001
[Initial success with topical immunomodulators. A creme for skin cancer? (interview by Renate Jackle)]. MMW Fortschritte der Medizin, 2001, May-24, Volume: 143, Issue:21 Topics: Adjuvants, Immunologic; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Melanoma; Neoplasms, Radiation-Induced; Ointments; Radiodermatitis; Skin Neoplasms; Treatment Outcome	2001
'Rub on' treatment for basal-cell carcinoma. The Lancet. Oncology, 2002, Volume: 3, Issue:4 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Ointments; Skin Neoplasms; Treatment Outcome	2002
Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2002, Volume: 28, Issue:6 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Tolerance; Facial Neoplasms; Female; Humans; Imiquimod; Male; Ointments; Skin Neoplasms; Xeroderma Pigmentosum	2002
Imiquimod 5% cream: a new treatment option for basal cell carcinoma. International journal of dermatology, 2002, Volume: 41 Suppl 1 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; CD3 Complex; Cytokines; Dose-Response Relationship, Drug; Drug Eruptions; Humans; Imiquimod; Interferon-gamma; Interleukins; Neoplasms, Fibroepithelial; Receptors, Cell Surface; Skin Neoplasms; Th1 Cells; Tumor Necrosis Factor-alpha	2002
Imiquimod stimulates innate and cell mediated immunity which controls virus infections and tumors. International journal of dermatology, 2002, Volume: 41 Suppl 1 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Carcinoma, Basal Cell; Condylomata Acuminata; Humans; Imiquimod; Immunity, Cellular; Immunity, Innate; Interferon Inducers; Keratosis; Papillomaviridae; Papillomavirus Infections	2002